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Dysphagia is a common clinical problem. It is a distressing symptom which impacts negatively 
on the quality of life (QOL) of patients. There is increasing recognition that assessing QOL gives 
a broader perspective when deciding on and assessing the effect of treatment of our patients. 
An abstract concept, QOL is perceived by many clinicians in South Africa as difficult to measure 
and hence they are reluctant use it to help with therapeutic decision making. There is a dearth 
of QOL information from third-world countries and there is no locally developed or validated 
tool to measure it. If we are to provide more holistic health care to our patients this situation 
needs to be rectified and an appropriate tool developed.  
Aim 
To develop a quality of life questionnaire specific for dysphagia relevant to our local population 
and validated it against established international questionnaires. The newly developed 
questionnaire needs to be comprehensive enough to measure general QOL as well as specific 
enough to be able to detect differences in QOL before and after treatment. Furthermore it 
needs to be brief and simple so as to be clearly understood and completed by our patient 
population with varied literacy competencies.  
Methods 
We formulated a questionnaire related to dysphagia and other symptoms commonly associated 
with it and named it the Greys Dysphagia Quality of Life (GREYS DQOL) questionnaire. The 
questionnaire contained questions pertaining to generic QOL issues as well as to dysphagia-
related QOL issues. We administered the questionnaire to a sample of patients together with 
two other internationally used questionnaires.  One of the international questionnaires, the 
Short Form 36 (SF-36) quality of life questionnaire is a fully validated generic quality of life 
questionnaire which is extensively used world-wide and in South Africa. The other, the 
Dysphagia Score (DS), is a dysphagia-specific questionnaire used internationally to assess 
patients with conditions presenting with dysphagia. We compared the results of the three 
questionnaires as well as the compliance of patients in answering the three questionnaires. 




One hundred patients were entered into the study. The majority were males in their sixth and 
seventh decade of life.  Most patients had no established diagnosis at the time of the study, but 
of those who did have a diagnosis, the most common cause of the dysphagia was malignant 
obstruction of the oesophagus. The literacy level amongst our patients was found to be low.  
Twenty three patients received no formal schooling and only 11 patients completed school to 
matriculation level. The quality of life of our sample population was poor according to all three 
questionnaires.  The mean score for patients on the SADQOL questionnaire was 61 where a 
score of 0 indicates the best quality of life possible and a score of 100 indicates the worst 
quality of life possible. The mean score for patients on the SF-36 was 30, where 0 indicates the 
worst possible quality of life and 100 the best possible quality of life. The mean score for 
patients on the dysphagia score was 7, where 0 is the best score and 10 the worst. 
The results of the new questionnaire correlated well with that of the international 
questionnaires, confirming test-validity. The compliance of patients in answering questions in 
the GREYS DQOL questionnaire was superior to that of the internationally used questionnaires. 
The level of education influenced the scores of the SF-36 but not those of the GREYS DQOL and 
DS. This makes the GREYS DQOL more appropriate for use in our patient population. 
Conclusion  
The GREYS DQOL questionnaire is simpler to comply with and correlates well with established 
international tools. We therefore consider it to be a good tool for assessing quality of life of 
patients presenting with dysphagia in South Africa. It can be used to assess QOL in our patients 
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Chapter 1: Introduction and Study Rationale 
 
Dysphagia means difficulty in swallowing and is a term used to describe the symptom associated with any 
abnormality of the swallowing process other than pain1. Normal swallowing is a complex and well-
coordinated process, which requires neural control regulated by interactions between cortical centres in 
both hemispheres of the brain, the swallowing centre in the brainstem, cranial nerves and pharyngeal 
receptors2. It comprises four phases; oral preparation, oral, pharyngeal, and oesophageal. Dysphagia may 
occur due to malfunction or anatomical defect of any of these four phases3.  
 
1.1 Dysphagia and the patient 
 
The ability to swallow and eat is a basic human function which is not only life-sustaining but also life 
enhancing. It can provide pleasure and comfort and is central to most social interaction. Dysphagia 
interferes with this ability and in so doing has an immediate impact on daily life. This distressing symptom 
has been linked to depression, social withdrawal and decreased self-esteem and has a significant negative 
impact on quality of life QOL4-7. Consequences of dysphagia are numerous and include malnutrition and 
lower respiratory tract infection secondary to aspiration. Malnutrition itself has numerous complications 
which negatively affect QOL2, 8, 9. Symptoms commonly accompanying dysphagia include regurgitation, 
chest pain and choking. These symptoms themselves will affect the QOL of patients and lead to social 
embarrassment rendering patients unwilling to eat in public or at social gatherings5. The causes of 
dysphagia are numerous and many of these conditions are incurable10, 11. Treatment is therefore palliative 
and aimed at improving quality of life (QOL) in these patients. This would include palliation of the 
dysphagia as well as palliation of associated symptoms. 
Algorithms for the objective assessment of dysphagia are well established1 but the same cannot be said of 
subjective data gained from patients’ perspective even though difficulty in swallowing has an immediate 
impact on daily life6. Patients are faced with a daily struggle to eat and drink for survival and mealtimes are 
often long and exhausting12.  
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The effect of any symptom on QOL is dynamic and may change over time. For example, depression and 
anxiety may lessen as adjustments are made in coping with the illness. In addition the same symptom and 
condition may have different effects on different patients. Patients’ expectations of treatment outcomes 
differ, making objective information less useful in managing certain illnesses13. 
General health measures of quality of life are not sufficiently sensitive to swallowing-related issues and 
there is a need for symptom-specific domains to capture meaningful data6, 14.  While dysphagia-specific 
QOL have been developed and validated in the first world6, this has not been done in the third world 
setting. 
 
1.2 Palliative care and quality of life in South Africa 
 
The World Health Organization defines palliative care as ‘An approach that improves the quality of life of 
patients and their families facing the problems associated with life-threatening illness, through the 
prevention and relief of suffering by means of early identification and impeccable assessment and 
treatment of pain and other problems, physical, psychosocial and spiritual’15. Palliative care is most 
commonly associated with cancer patients, but it can be applied to all patients with incurable diseases.  
QOL measurement is an important aspect of palliative care, given that maximizing the QOL of terminally ill 
patients is the main aim of this type of care16.  
Palliative care is an essential component of public health services in South Africa and is accompanied by 
significant challenges, including lack of resources, poor socio-economic conditions and a lack of trained 
palliative care personnel17. While South Africa has made sustained gains in palliative care provision, these 
are mainly through community based hospices and home based palliative care programmes and not 
necessarily in State hospital facilities, which experience huge pressure on bed numbers on a daily basis15, 17. 
Progress has been made in certain key areas of palliative care in South Africa, such as the development of 
national standards for cancer pain management 18. 
A major barrier to the further development of palliative care in South Africa and Africa as a whole is the 
lack of data to inform service provision. There is a dearth of palliative care outcome measures developed 
and validated in South Africa19. Palliative care research in Africa has predominantly focussed on opioid 
availability and physical aspects of care, such as the assessment of pain and other symptoms, while 
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neglecting holistic outcomes such as QOL. In the developed world there has been rapid growth in QOL 
research that aims to understand patient experience, identify patient needs and evaluate the effectiveness 
of interventions and services. However, to date there has been very little research in this area in Africa, 
despite recognition of the importance of outcome measurement and the need to identify domains in which 
patients may need specific support15, 19. 
The functional status of patients declines as the latter stages of terminal disease approaches and is a good 
prognostic indicator20. Hospice patients have been shown to score lower in psychophysiological and 
functional well-being than healthy subjects but not necessarily lower in social and spiritual domains. The 
reasons for this are not clear but changes in priority and adaptation to life situations may play a role21.  
Measurement of QOL may clarify some of these findings and is therefore central to assessment of palliative 
care. 
 
1.3 Measurement of quality of life 
 
As physicians we often under appreciate the effects of a disease or symptoms on quality of life. We gauge 
treatment success by assessing so-called ‘hard data’ like survival, results of radiological investigations and 
laboratory results. If we are satisfied with these results then we are more likely to repeat the same course 
of treatment with other patients. We forget to assess whether our treatment has actually helped the 
patient. We forget to assess the effects of our treatment on the QOL of our patients. Little, if any, insight is 
gained from the patient regarding the success of the treatment. One of the reasons for this is the lack of 
tools which adequately assess QOL, and particularly disease or symptom specific QOL. Another reason is a 
lack of awareness of the importance of QOL when treating patients22-24. 
Quality of life is a term which applies to various aspects of life including politics, economics and spirituality. 
In the medical context, it is health-related QOL (HRQOL) which we are more concerned with. HRQOL 
measures the effects of symptoms, diseases and its treatment on the patient’s overall well-being25. 
Patients often present to clinicians with symptoms or disabilities and treatment should be aimed at 
relieving these complaints and thereby improve QOL. Measuring outcomes in this context is challenging. 
The World Health Organization (WHO) framework of disease consequence is useful in assisting clinicians in 
choosing an outcome measure. The framework divides disease consequences into impairments, disabilities 
and handicaps. Each of these outcomes provides complementary information and has relative advantages 
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and disadvantages in assessing QOL. Impairments are restrictions of physiological or anatomical structure 
or function, disabilities are restrictions to perform activities within what is considered normal range and 
handicaps are restrictions that limit fulfilment of a usual role, like doing housework26. Measures of QOL are 
useful in assessing outcomes of treatment as they take input from the patient into consideration. These 
measures are usually classified as generic or specific.  
Generic measures provide a broad general picture of the patient’s health and include physical, mental, 
social and psychological aspects. Generic measures have the advantage of providing a comprehensive 
assessment of health and it allows for comparison across different population groups. The major 
disadvantage of generic measures is that they are not responsive to change in individual patients’ 
conditions or to change after treatment has been administered.  
Specific measures may be disease, symptom or population specific and focus on aspects of health care that 
are specific to an area of interest. They have the advantage of being more responsive to changes in QOL 
after intervention and of relating closely to areas routinely analysed by clinicians. The major drawback of 
specific instruments is that they have a relatively narrow focus compared to generic tools and therefore 
give limited information regarding overall health and QOL. To provide a complete assessment it may 
therefore be necessary to combine aspects of generic and specific questionnaires23-27. 
 
1.4 Study rationale 
 
While there are a number of tools available to assess QOL in patients, the majority of these tools are 
developed in first world countries and many of the questions have little relevance to our local population28. 
Therefore their use in our local setting is questionable. This is understandable since health HRQOL is 
influenced by culture and perception29. Culture may be defined as ‘the integrated patterns of human 
knowledge, beliefs and behaviour’. It is known to impact on health attitudes, belief and behaviour30, 31. 
Many of the questions are related to social and economic factors which differ vastly between first and third 
world countries.  
Another problem with these instruments is that they have been tested in population groups that differ in 
many aspects from our patient population. Many of the questions focus on issues that are important to 
these population groups and these issues may not be as important to our patients. Issues that are 
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important to our patients are not addressed. For example, questions asked in the short-form 36 health 
survey make reference to health limiting activities like playing golf or pushing a vacuum cleaner. While 
these issues may be important to individuals from first-world countries, many of our patients may not even 
know what golf or a vacuum cleaner is. Loss of weight may carry more significance with some of our 
patients compared to patients elsewhere. In addition concepts such as pain and anxiety can lack both intra- 
and intercultural equivalence among the divergent ethnic groups across South Africa. The impact of 
culture, in general, would affect results of QOL research in South Africa.  
Objective assessment of swallowing dysfunction is well established, widely practised and include contrast 
and motility studies5, 32, 33 while good quality validated tools for the more subjective QOL effects of 
dysphagia are lacking in comparison8. Dysphagia specific quality of life tools have been developed and 
validated in the first world34, 35 but not in South Africa. Furthermore, there is discrepancy in the literature 
with respect to the correlation between objective and subjective swallowing evaluation5. There is therefore 
a need to develop QOL questionnaires that contain questions regarding dysphagia that are relevant to our 
local population. These should include both generic and disease or symptom specific questionnaires. The 
questions asked should address issues that are important to our patients. These questionnaires should be 
validated and used to assess the impact of disease or symptoms on our patient as well as the effectiveness 
of different treatment regimens, particularly those that are aimed at improving QOL rather than cure. 
Health care givers should be made aware of the importance of quality of life when caring for patients. 
 
1.5 Outline of the thesis 
 
The factors outlined  above are detailed in the literature review which provides the relevant background to 
look at the impact of dysphagia on health in general, the progress made thus far with development of 
quality of life questionnaires and the results of similar studies. The methodology describes the 
development of our own Dysphagia QOL questionnaire and it comparison with existing validated 





Chapter 2: Literature Review 
 
 
Developing an assessment tool for studying the impact of dysphagia on quality of life (QOL) in a South 
African context requires an understanding of the literature addressing these topics. This chapter reviews 
the key concepts necessary to understand the complexity of the task. It then presents analyses and 
discusses the pertinence of largely internationally developed questionnaires used in studies addressing the 
symptom of dysphagia. The literature provides a framework for the rationale of the study and the 





Dysphagia is a term which means difficulty in swallowing. The term itself is subjective, broad and non-
specific. Swallowing is a highly complex process involving both voluntary and non-voluntary components 
and the intricate coordination of muscles and nerves. The ability to swallow safely and efficiently is a basic 
human need and an essential daily experience associated with the pleasure of eating 3, 36. Dysphagia should 
not be confused with odynophagia which is ‘painful swallowing’1. 
Any disruption or abnormality in the swallowing process may be defined as dysphagia. Persons with 
anatomical or physiologic deficits in the mouth, pharynx, larynx, and oesophagus may present with 
dysphagia. There are two types of dysphagia: oropharyngeal or ‘high’ dysphagia and oesophageal or ‘low’ 
dysphagia. The majority of patients we are exposed to as surgeons present with oesophageal dysphagia1, 3. 
2.1.2 Quality of life 
‘Quality of life’ (QOL) as a concept is not easy to define. It is a broad concept encompassing a number of 
aspects ranging from standards of living to psychological, physical and social aspects of life. In other words, 
it is a comprehensive concept that includes objective and subjective aspects37. 
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There are a number of attempts to define QOL however. The Group Quality of life at the Division of Mental 
Health from the World Health Organization defined QOL as ‘the individuals’ perception of their position in 
life in the context of the culture and value systems in which they live and in relation to their goals, 
expectations, standards and concerns.’37. In another definition it is defined as ‘a broad range of human 
experiences related to one’s overall well-being’. It implies value based on subjective functioning in 
comparison with personal expectations and is defined by subjective experiences, states and perceptions38. 
Quality of life, by its very nature, is unique to the individual, while being easily understood by most 
people38. 









The physical, psychological and social domains are considered to be the three main dimensions of QOL. The 
physical domain refers to the ability to carry out daily activities and tasks that require energy expenditure, 
as perceived by the patient. The psychological domain incorporates aspects of emotional and mental well-
being like depression, anxiety, fear and happiness and the social aspect refers to the patient’s ability to 
relate to and interact with members of family, friends and acquaintances40. 
The subjective nature of QOL affects our ability to measure it. QOL depends on an individual’s perceptions 
and therefore self-appraisal is a key factor in studies assessing QOL. In addition to being subjective, it is 
dynamic and changes over time. This change may be influenced by a number of patient and environmental 
factors. It may therefore be necessary to carry out repeated assessments41, 42.  
QOL includes both positive and negative dimensions39. Positive dimensions include aspects like role 
functioning and contentment while negative dimensions include aspects like pain and feelings of 
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depression. How much someone enjoys life and how much pain affects someone are both important 
aspects of QOL assessment43. 
As clinicians we are largely interested in health-related quality of life (HRQOL) because widely valued 
aspects of life exist that are not generally considered as ‘health,’ including income and freedom25. It has to 
be kept in mind though that almost all aspects of life can become health related. HRQOL is therefore often 
used interchangeably with overall QOL. Because illness and treatment affect the physical, psychological and 
social well-being of an individual, any definition of HRQOL should be all encompassing while allowing 
individual components to be assessed individually44. 
HRQOL can be defined as ‘self-perceived aspects of well-being that are related to or affected by the 
presence of a disease or treatment’. It includes the negative aspects of symptoms caused by a disease 
and/or its treatment29. It is important to measure HRQOL because physiological measures often correlate 
poorly with functional capacity and well-being and two patients with similar clinical criteria often have 
dramatically different responses25. 
This multidimensional concept should be defined from the perspective of the patient and clinicians should 





The exact incidence of dysphagia is difficult to ascertain and depends on a number of factors, including the 
population group being studied and the level of health care provided in a particular setting. The reported 
incidence and prevalence of various forms of dysphagia vary depending on a number of factors and 
epidemiological data cannot be provided on a global basis since the prevalence of most diseases that may 
present with dysphagia tends to differ between different parts of the world. Also, prevalence will vary 
depending on the age of the patient, and it should be remembered that the spectrum of disorders in 
childhood dysphagia is different from that of adult-onset dysphagia. Therefore, only approximations are 
possible on a global scale. Generally, dysphagia occurs in all age groups but its prevalence increases with 
age. First-world statistics reports the prevalence of dysphagia in a primary care setting to be between 20% 
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and 25%. The prevalence increases to 30% in general medical wards and is as high as 60% in nursing 
homes7, 36, 46, 47. It is therefore a common problem encountered in clinical practice. 
2.2.2 Causes  
The causes of dysphagia are vast and depend on the type. Oropharyngeal dysphagia is most commonly 
caused by neuromuscular diseases like Parkinson’s disease or stroke while oesophageal dysphagia is most 
commonly caused by mechanical obstruction of the oesophagus or motility disorders of the oesophagus1. 
Dysphagia complicates up to two thirds of cases of stroke while healthy ageing alone may affect the 
swallowing process14. However, the majority of patients presenting to a surgical department have a 
mechanical obstruction of the oesophagus, pharynx or mouth and in a large proportion of these patients, 
the source of the mechanical obstruction will be a malignancy. The common causes of dysphagia are listed 
below1, 13, 14: 
 Cancer of the oesophagus 
 Gastroesophageal reflux disease 
 Motility disorders of the oesophagus 
 Head and neck cancer 
 Oesophageal diverticulae 
 Stroke  
 Neurodegenerative disorders e.g. Parkinsons 
 Oesophageal webs 
 Extrinsic compression e.g. thyroid goitre 
 
2.2.3 The effects of dysphagia 
Dysphagia as a symptom can have devastating effects on patients. It is associated with increased morbidity 
and mortality. Cowen and colleagues found that mortality was high in patients with severely abnormal 
swallowing and that advanced age, reduced serum albumin concentration, disorientation to person and 
higher morbidity scores were independent predictors of mortality48. This increased risk of death was 
independent of the actual cause of dysphagia48. 
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The physical consequences of dysphagia are vast and include malnutrition, dehydration and respiratory 
infections. Untreated, any of these conditions may lead to death7, 49. Dysphagia may even be seen as a 
handicap, where handicap is defined as ‘a reduction in functional capacity that limits the individual’s ability 
to attain his or her physical goals’7.However, the treatment of dysphagia can result in improvement of 
these conditions50. 
Dysphagia contributes to a variety of mental disorders; most notably, anxiety and depression as well as 
negative effects on social aspects of health2, 7, 36, 47, 51. It is considered a disabling condition for an individual 
in terms of both the functional, as well as the emotional aspects51. Dysphagic patients perceive their ability 
to eat out or engage in social activity as being reduced2. Studies assessing the psychosocial aspects of 
dysphagia found that 41% of dysphagic individuals experienced anxiety or panic during meals and 36% 
avoided eating with others leading to increased feelings of social isolation and loss of self-esteem7. 
Reductions in self-confidence, social relations, and increased isolation were commonly experienced by 
these patients. Progressive dysphagia was found to be independently associated with depression and 
impairment of general health. Addressing the symptom of dysphagia itself with counselling and speech 
therapy can lead to an improvement in QOL7,47, 51. 
2.2.4 Evaluation of dysphagia 
Table 1 (see p 12) summarises the studies looking at the measurement of dysphagia as a primary symptom 
among patients. In an analytical review of dysphagia scales, Sallum and colleagues compared dysphagia 
scales used in the literature in order to find the most objective tool for evaluation and follow up of 
dysphagia and came up with some interesting findings52. They found that most scales do not meet the 
requirements to be classified as a complete tool in the evaluation of any dysphagia. Many were specific to 
a certain disease and the few which had global evaluation had no statistical consistency to strengthen their 
assessments. The heterogeneity of the population groups in these studies makes comparisons between 
them difficult but each tool has its pros and cons and their usefulness depends on a number of factors 
including the aim of use.  
The Dysphagia Handicap Index differentiates between patients with dysphagia and individuals without 
dysphagia with high reliability and validity. It was found to be sensitive to differences in scores based on 
severity of dysphagia and to be suitable for use in individuals with lower literacy levels53. When dysphagia 
and associated symptoms are compared to manometric findings using a weighted priority symptom score, 
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they are not always predictive of diagnosis. This emphasises the importance of subjective symptom 
evaluation over manometry in patients with dysphagia54. When symptom severity and frequency is added 
for dysphagia and associated symptoms, the resultant scores are useful in monitoring symptoms before 
and after surgery55.  
The Dysphagia Outcome and severity scale rates the functional severity of dysphagia based on objective 
assessment. While the scale showed good inter-rater agreement it was found to be limited due to the 
possibility of interpretation bias, making it a poor tool for follow up assessment56. The clinical dysphagia 
scale which is a dysphagia rating scale that can be used at the bedside to quantify the severity of dysphagia 
and predict the risk of aspiration in patients suffering from dysphagia relies on information from the 
clinician rather than the patient but shows excellent inter-rater agreement and proved to be a useful tool 
for the reliable detection of dysphagia57. Finally, using the frequency and severity of dysphagia alone as an 




Table 1: Studies assessing the measurement of dysphagia 
Year Name of 
dysphagia scale 
Author Condition  Strengths  Weaknesses  
2012 DHI Silbergleit
53 
Variety  Covers both high and low dysphagia. 
Applicable to patients with lower 
literacy level 







Demonstrated association between 
symptoms and manometric findings. 
Brevity  
Affected by limitations of 
manometry. Biased to 




Variety  Good statistical concordance Only applicable in high 
dysphagia 
1999 DOSS O’ Neil
56 












Validated. Proven reliability Results obtained as multiple 
scales. Long questionnaire 
2007 DS Youssef
58 
achalasia Good practical application Lacks comprehensiveness 
DHI – Dysphagia Handicap Index   WPSS – Weighted Priority Symptom Score  CDS – Clinical Dysphagia scale 
DOSS – Dysphagia Outcome and Severity Scale FOIS – Functional Oral Intake Scale  ASDS – Acute Stroke Dysphagia Screen 
SWAL-QOL – Swallow QOL   DS – Dysphagia Score 
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These studies highlight the lack of tools to evaluate dysphagia in a holistic manner. There are 
several assessment tools to analyse the symptom, but most of them are specific to a single 
disease53. There is still a need for more validated dysphagia-specific QOL tools. 
 
2.3 Quality of life 
 
The concept of QOL is not new and dates back in its origins to classical Greece. The subject was 
addressed by Aristotle in lectures given at the Lyceum in Athens and subsequently edited by his 
son as ‘Nicomachean Ethics’, in which is introduced the concept of ‘eudaimonia’ or well-
being/happiness59. 
2.3.1 QOL measurement 
QOL is usually measured by administering structured questionnaires which consist of a number of 
items that tap into different dimensions of QOL. The answers are given a score which makes it 
possible to obtain quantitative data from qualitative information. There are a number of modes of 
administration including self-administration, interviewer-administered and surrogate responder. 
Each of these modes has strengths and weaknesses. For example, self-administered 
questionnaires allow the respondent to divulge personal sensitive information more readily and 
use minimal resources but come with a greater likelihood of poor response rates and missing data. 
Interviewer-administered questionnaires on the other hand maximises response rates but may 
reduce willingness by the patient to divulge sensitive information. The mode of administration 
chosen should take into account the information required in a clinical setting and the aims of the 
study in a research setting25, 40. 
2.3.2 Properties of a good QOL instrument 
Key properties of a good QOL instrument are validity, reliability and responsiveness. Validity 
examines whether an instrument measures what it intends to measure. Reliability implies that the 
instrument will produce consistent results after repeated administration and responsiveness is the 
ability to detect any changes in QOL resulting from disease or treatment25, 60, 61.  The structure of 
the questionnaire is an important consideration. The question ‘How is your quality of life’ would 
yield limited information. A number of questions need to be asked in order to create a number of 
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domains. A domain refers to the area of behaviour or experience that we are trying to measure. 
The importance of each item in relation to the others also needs to be taken into account25. 
2.3.3 The importance of QOL measurement 
The analysis of the influence of a chronic disease on different dimensions of QOL might help to 
identify effective treatments to improve the physical and psychological state of a patient62. 
Combining generic and disease or symptom specific questionnaires may avoid missing unexpected 
outcomes and ensure recognition of all clinically important changes63. Generic HRQOL instruments 
are designed to be applicable across all diseases or conditions, across different medical 
interventions and across a wide range of populations. In contrast, specific or targeted HRQOL 
measures are designed to be relevant to a particular condition or state28.  
There are many ways in which measurement of QOL can help improve patient care and outcomes, 
namely:64 
 Improving efficacy assessment of different treatment modalities 
 Indicating a need for supportive interventions 
 As a prognostic indicator 
 Aiding decision-making 
 Informing resource allocation and healthcare policy 
 
Improving the efficacy assessment of different treatment modalities is of particular importance in 
situations where the only treatment available to the patient is palliative, as in cases of advanced 
malignancy. Supportive interventions are important considerations when taking side-effects of 
different treatment regimens into account and this information can often only be obtained from 
the patient. QOL is well known as a prognostic indicator and input from patients about effects of 
different treatment options can aide in decision making. Resource allocation and health-care 
policies are largely dependent on QOL assessments in many countries. The prognostic significance 
of QOL is well established44, 65. For example, patient-reported outcomes (PRO’s) have been shown 
to be better predictors of survival than computer tomography scans in patients with metastatic 
colorectal cancer. QOL can therefore possibly be used as a surrogate marker for improved survival 
in clinical trials. Patient-reported outcome assessment is gaining increasing importance in both 




2.4 Patient-reported outcomes  
 
Patient-reported outcomes (PRO’s) are assessment tools which in essence reflect how medical or 
surgical treatment, irrespective of the approach, can alter appreciably the quality of life of 
patients who seek treatment for relief of symptoms caused by specific disorders. Patients’ 
satisfaction with the treatment depends largely on relief or significant improvement in their 
symptoms, but it is also influenced by their experience and the quality of the entire process of 
treatment. PRO’s include a cluster of variables: HRQOL, symptoms, physical functioning, 
psychological well-being, treatment satisfaction, and treatment preferences59. The inclusion of 
these variables in the assessment of patients results in a more comprehensive and global 
assessment of patient care. Scientific evidence for the reliability of PROs was first reported in the 
1970s with pain reporting and continued with studies that showed that patient-reported versions 
of performance status and symptom distress were prognostic for survival. The importance of 
assessing PRO’s is reported in a number of publications66-69. Several authors illustrated the 
different points of view of clinicians and patients in rating the relative importance of different 
outcome measures. Suggestions from symptom research indicate that clinicians report fewer 
symptoms of lower severity than patients and that patient self-reporting could improve 
management of symptoms by notifying the clinician about objective symptoms, and alerting 
clinicians to patients’ perceptions of the severity of more subjective symptoms (which might differ 
from their own perceptions)67,68. 
2.4.1 The importance of PRO’s 
Today measures of symptoms, health-related quality of life (HRQOL) and patient satisfaction are 
considered to be important and appropriate endpoints of outcome. Both physiological and 
patient-reported outcomes are important; the physiological measures reflect the system used by 
the professionals to obtain information that helps establish the efficacy of the intervention, thus 
confirming their clinical impression. The patient-reported measures reflect the subjective 
evaluation and reporting of the illness experiences and its treatment. The three most important 
aspects of PRO to consider are symptoms, HRQOL and patient satisfaction70. 
Patients usually consult their doctors because they experience one or more symptoms that signify 
an unpleasant and unwelcome change in their body. If after treatment the symptoms are 
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abolished or become less severe, the treatment was successful from the patients’ perspective.  
Symptoms can be specific, like heartburn in GERD or rectal bleeding in patients with rectal cancer. 
Some symptoms, for example pain, are not specific and occur in almost every disease. Symptoms 
can be assessed separately or as part of a QOL questionnaire70. 
Doctors often assess results of treatment by objective measures like morbidity, survival and 
results of laboratory and radiological tests. Yet there may be a discrepancy between these 
objective measures and the functioning and feelings of the patients. These subjective measures 
can be documented by quality of life scales70. Many postsurgical patients, despite normal 
investigations and laboratory results, experience an extremely impaired quality of life71. This 
highlights the importance of PRO’s relative to objective clinical variables. 
Patient satisfaction is the patient’s own perception of both the quality of treatment provided and 
its effectiveness, embodied in the ‘‘patient experiences’’.  A measure of satisfaction documents 
patients’ assessments or affective responses to different dimensions of the treatment experience. 
Such a measure gives information about the relationship between patient expectations and the 
treatment experience, and it can incorporate different aspects such as: (a) description of health 
care from the patient’s viewpoint; (b) measurement of the process of care; and (c) evaluation of 
its outcome66-70.  
2.4.2 Conceptual framework 
Different conceptual frameworks for understanding patient satisfaction have been proposed, and 
used as the basis for the development of measures. The patients’ life experiences, education, and 
personal characteristics influence their expectations before treatment as well as satisfaction 
during and after the treatment. Individual expectations and satisfaction with the components of 
treatment are also independent predictors of overall satisfaction70. As an example, Holzer et al. 
evaluated the relationship between the preoperative expectations in patients with colorectal 
cancer and their age, gender, and socioeconomic status. These authors learned that while, as 
expected, complete cure of the disease was the prime expectation of the vast majority of patients; 
age, gender, and education had a significant influence on patient expectations72. Pettersen et al. 
developed and validated the patient experiences questionnaire, a self-report instrument that has 
ten rating scales including information on complaints, nursing services, communication, 
information examinations, contact with next-of-kin, doctor services, hospital and equipment, 
17 
 
information on medication, organization, and general satisfaction. They tested it on patients 
discharged from surgical and medical wards. The authors concluded that because there is no 
standard method or ultimate instrument for measuring patient experiences, there is a need to 
develop new questionnaires and scrutinise existing ones. The choice of instrument chosen would 
depend on not only on psychometric properties, but also on the health care system, the purpose 
of the study and in what setting it is carried out73. 
2.4.3 When obtaining PRO is not possible 
There are situations in which it might not be possible to obtain the desired information from 
PRO’s. Problems with self-report may arise when patients have insufficient cognitive or 
communication abilities, when they experience severe symptom distress, or when they find an 
interview to be physically or emotionally too taxing. Under these circumstances it may be feasible 
to obtain QOL information from their significant others or health care providers. These surrogate 
providers, or proxies, should be able to provide reliable and useful data on a range of HRQL 
domains, including patients’ physical and psychosocial functioning, and a variety of physical and 
mental symptoms74. There is usually moderate agreement between individual patients and their 
proxies, although lower levels of agreement may be reported for psychosocial functioning. While a 
number of factors affect the degree of agreement between patients and proxies, significantly 
important determinants of agreement between ratings of a proxy and a patient have yet to be 
identified68-70. The ideal tool to obtain information about a patient’s QOL from a surrogate 
provider does not exist and still needs to be developed. Whether this will be at all possible 
remains to be seen and further research is needed on the topic.  
The increasing importance of PRO’s, both in research and clinical application, cannot be denied. It 
has been shown that patients can understand and report the severity of their symptoms and 
those patient-reported versions of performance status and symptom distress are prognostic for 
survival45, 75. Physicians tend to underestimate the importance of subtle symptom-related 
problems75. Patient reporting is reliable in documenting the severity of specific disease-related 
patient symptoms, typically by the use of a linear analogue scale. Issues that still need to be 
addressed include thorough calibration of PROs for symptom monitoring and verification of the 
psychometric properties of these assessments. Information provided by patients on their 
condition and satisfaction with treatment is a key component of clinical care. The challenge is to 
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find efficient, sensitive, specific, practical, and understandable assessments to calibrate and 
interpret this information66. 
 
2.5 QOL instruments and dysphagia 
There are a large number of QOL instruments available in the literature. While many are used in 
clinical trials, there use in clinical practice has not been established. This is despite the recognition 
that clinical and physiological assessments do not always provide a complete picture of the impact 
of disease on the well-being of the patient and that QOL assessments need to be integrated into 
overall patient assessment76. Not all instruments are fully validated and there may be 
circumstances in which specific tools are inappropriate for use in different population groups, 
despite these population groups sharing the same or similar disease processes. Choosing the 
correct instrument can therefore be a complicated process.  
2.5.1 Classification 
The different types of QOL instruments are listed below25. Both generic and disease-specific 
measures can be used to evaluate health-related quality of life. Generic instruments have the 
advantage of allowing comparisons among different diagnostic groups or to healthy populations. 
However, generic instruments may not tap particular domains relevant to the disease of interest 
and thus may not be sensitive enough to monitor health-related quality of life for a specific 
patient population76. 
Generic instruments 
 Health profiles 
 Preference based measurements 
 
Specific instruments 
 Disease-specific (e.g. Achalasia) 
 Population-specific (e.g. Africans, Elderly) 
 Function-specific (e.g. sexual functioning) 




2.5.2 Medical Outcomes Study 36-item Short form health survey (SF-36)  
The SF-36 is a widely used health status questionnaire comprised of 36 items selected from a 
larger pool of items in the medical outcomes study (MOS)28. The SF-36 health survey items were 
selected to maximise their associations with the long-form MOS scales from which they were 
derived. It is a shortened version of 149 validated health-related questions originally reported as 
part of a medical outcomes study. In order to maintain comprehensiveness the Sf-36 was 
shortened by representing health concepts most frequently included in widely used health 
surveys77. 
The SF-36 health survey looks into eight health concepts encompassing physical and mental 
aspects of QOL. Factor analyses of the SF-36 health survey provide strong support for a 2-factor 
model of health, with physical health reflected primarily by measures of physical functioning, pain 
and role limitations due to physical health problems, and mental health reflected primarily by 
measures of emotional well-being and role limitations caused by emotional problems78.  
The SF-36 is useful for assessing health in a global manner; for example, the SF-36 has been used 
around the world to assess QOL in patients with a variety of different chronic disease79. However, 
the SF-36 is often not sensitive enough to detect small differences in specific treatment groups 
with unique health care disabilities. Specific health-care instruments are tailored to detect these 
small differences in QOL when treatment groups are more homogeneous. These questionnaires 
are specific to a type of disease, population, domain, or symptom27. 
The experience to date with the SF-36 has been documented in more than 1000 publications. It 
has been validated in the literature and has been widely adopted because of its brevity and its 
comprehensiveness. The content validity of the SF-36 has been compared with that of other 
widely used generic health surveys and comparisons indicate that the SF-36 includes eight of the 
most frequently measured health concepts80. 
The SF-36 has been utilised for four distinct goals, namely 
 To assess the effect of a condition on QOL 
 To assess treatment outcome 
 To compare the effect of treatment options for a given condition 
 To compare the effect of a procedure against other unrelated procedures 
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Because of its widespread use, many other questionnaires are validated by examining its 
concordance with the SF-3634, 76, 82-85.  
The SF-36 and dysphagia 
A number of studies used the SF-36 to assess QOL in patients suffering from conditions causing 
dysphagia. Some of these are listed below in Table 2: 
Table 2: Studies using SF-36 to assess QOL in dysphagic patients 
Year  Author Condition Additional questionnaires Other information 
2001 Dallal
86 
Oesophageal cancer EORTC QLQ30, EORTC OES24 Thermal ablation vs. SEMS  
2001 Chen
34 
Head and neck 
cancer 
MDADI Dysphagia in H&N cancer 
2004 Mineo
87 
Achalasia  Long term outcome of Heller myotomy  
2007 Youssef
58 
Achalasia Dysphagia score QOL after Heller myotomy 
 
These studies showed that the SF-36 is an appropriate tool in the measurement of QOL in 
dysphagic patients. It may be used to validate newly developed instruments and has shown good 
responsiveness when assessing QOL in these patients. There is good correlation between SF-36 
scores and severity of dysphagia in patients34, 58, 86, 87. 
The SF-36 questionnaire is therefore an appropriate tool to assess QOL in patients suffering from 
dysphagia. 
2.5.3 Dysphagia score 
There are a number of dysphagia scores available in the literature2, 34, 88. Some assess severity 
and/or frequency of dysphagia while others assess the degree of dysphagia in relation to food 
types. 
Richards and colleagues used the Dysphagia score which adds severity and frequency of the 
symptom as part of an assessment comparing Heller myotomy with and without fundoplication 
for Achalasia89. It was subsequently used by other authors to assess success of surgery for 
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Achalasia58, 90. Achalasia is a motility disorder of the oesophagus. The pathophysiology is not fully 
understood but involves the selective loss of inhibitory neurons in the myenteric plexus, leading to 
the production of vasoactive intestinal polypeptide, nitric oxide, and inflammatory infiltrate 
responsible for lower oesophageal sphincter (LES) dysfunction. An unopposed excitation of the 
sphincter causes its dysfunction or failure to relax in response to swallowing91. Since dysphagia is 
the cardinal symptom of achalasia, the improvement of dysphagia will result in improvement of 
QOL. The score itself can then also be used to assess QOL in patients with dysphagia secondary to 
other conditions. While it is short and simple it is inadequate in assessing QOL as it only asks 
questions regarding the severity and frequency of dysphagia. 
2.6 Studies assessing QOL 
 
A number of factors can affect QOL, particularly HRQOL. Chronic disease and its treatment, 
whether pharmacological or surgical, influence the physical and psychological health of a 
patient62. Similarly, specific symptoms can impact on QOL. The impact of dysphagia on QOL has 
been assessed using generic, disease-specific and symptom specific QOL measures. The effects of 
different treatment strategies have been assessed in specific conditions as well as in a variety of 
conditions causing dysphagia34, 52, 58, 88. 
2.6.1 Assessment of dysphagia and its treatment in patients with cancer of the oesophagus 
Dysphagia is the predominant symptom in the vast majority of patients with cancer of the 
oesophagus. Most patients diagnosed with oesophageal cancer are either not fit for curative 
surgery or are diagnosed at an advanced stage of disease, making palliative management the only 
option. The palliation of dysphagia has been practised for more than a century. Early attempts at 
palliative treatment of malignant dysphagia were met with constant failure. In 1959, Celestin 
described the palliation of malignant dysphagia using a plastic endoprosthesis introduced at 
laparotomy92. This form of treatment worked well and became popular over the next few 
decades. Endoscopic introduction of plastic stents was introduced in the 1970’s eliminating the 
morbidity associated with laparotomy, but it was the introduction of self-expanding metal stents 
in the 1980’s that revolutionised the palliation of malignant dysphagia. There are a number of 
options available for palliation of malignant dysphagia, e.g.  Intraluminal brachytherapy, laser 
therapy and photodynamic therapy. While systemic reviews have shown no difference in the 
efficacy of the different options, oesophageal stenting with self-expanding metal stents remain 
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the most commonly used intervention. The single biggest advantage over other means of 
palliative treatment of malignant dysphagia is that stenting provides immediate relief of 
symptoms that lasts longer than that obtained after dilation alone93-95. 
A number of studies assessed quality of life in patients undergoing palliative treatment for 
oesophageal cancer. The instruments used in these studies ranged from generic to specific. The 
specific instruments are further divided into those that are cancer specific and those that are 
specific to oesophageal cancer96.  
2.6.2 Disease-specific QOL assessments 
When it comes to disease-specific QOL instruments related to dysphagia, Achalasia and Gastro-
oesophageal reflux disease (GORD) received the most attention. Achalasia is a motility disorder of 
the oesophagus due to loss of ganglion cells resulting in incomplete relaxation of the lower 
oesophageal sphincter on swallowing and lack of peristalsis. Dysphagia is the cardinal symptom. 
There are a number of treatment options available. None are curative and therefore QOL 
assessment is an integral part of the management of these patients. GORD is a disease caused by 
reflux of gastric content into the oesophagus resulting in a variety of symptoms including 
heartburn and dysphagia. 
Several authors set out to develop and validate Achalasia-specific or GORD-specific QOL 
questionnaires and achieved variable success. Some of these involved translation of existing 
questionnaires but this only applied to European languages. Most of these questionnaires were 
tested for correlation with generic health measures like the SF-3663, 84, 85, 97. 
2.6.3 Symptom-specific QOL assessments 
Chen and colleagues were the first group to develop a self-administered questionnaire designed 
specifically for evaluating the impact of dysphagia on QOL of patients with head and neck cancer. 
They started by forming focus groups consisting of Doctors and a speech pathologist. Patients with 
head and neck cancer were later added to the focus group and a questionnaire was developed. 
The questionnaire, which was called the M. D. Anderson Dysphagia inventory, was administered 
to one hundred patients together with the SF-36.  The questionnaire was evaluated for reliability 
and validity. They also concluded that disease-specific instruments assessing QOL are more 
responsive to changes in patient status over time than their generic counterparts34.  
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The SWAL-QOL quality of life and quality of care outcomes tools were developed and validated by 
McHorney and colleagues. The original questionnaire contained 93 items and was too long for 
practical use, so they reduced it into 2 patient-centred outcomes tools: (1) the SWAL-QOL, a 44-
item tool that assesses ten quality of life concepts, and (2) the SWAL-CARE, a 15-item tool that 
assesses quality of care and patient satisfaction.  They found that 33% of their dysphagia patients 
met clinical criteria for major depression88. This implies that it is an under detected problem in 
patients with dysphagia and underscores the importance of assessing mental health and QOL in 
patients with dysphagia.  
Silberglite and colleagues set out to develop a develop a clinically efficient patient-reported 
outcomes tool that measures the handicapping effect of dysphagia on emotional, functional, and 
physical aspects of individual’s lives. They compiled a series of dysphagia complaints made by 
patients during a one month period. The result was a 25-item test consisting of three scales; 
physical, emotional and functional. While most of the patients who participated reported mild or 
moderate dysphagia and few reported severe symptoms, they found that dysphagia had a 
significant impact on QOL53. 
2.7 Adaptation and translation of QOL questionnaires 
 
Assessing QOL of patients in South Africa is a challenging concept. South Africa is a country with 
diverse cultures and languages. Often there is a distinct difference between the patient 
population and health care givers in terms of economics and cultural issues. Language barrier is a 
common problem in clinical practice98. Comparing self-reported quality of life issues across 
different population groups is a practice fraught with problems since HRQOL is a complex function 
of socioeconomic variables including education, household income and cultural conceptions of 
health99. 
 Mullin et al. investigated the feasibility of translating a QOL instrument into three South African 
languages (Pedi, Tswana and Zulu). They translated the Functional Assessment of Cancer Therapy 
(FACT) questionnaire into the three languages and then administered them to patients. They 
found the challenges of considering social and cultural contexts in translations to be significant. 
They found their results to be encouraging and suggested further research in translating 
international questionnaires into African languages98. 
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Jelsma et al. examined the reliability and validity of a Xhosa version of the EQ-5D which is a 
generic HRQOL measure that has been used as an outcome measure for a wide-variety of 
conditions, including cancer. They faced the same challenges as we did, including the lack of a gold 
standard but nevertheless reported reasonable validity and reliability of the instrument. Like the 
GREYS DQOL, the EQ-5D also used the VAS and this was a useful feature, especially for patients 
with lower literacy levels100. They used the same questionnaire to examine the determinants of 
self-reported HRQOL in a culturally and socially diverse South African community in the Western 
Cape. They concluded that the VAS is a valid measure of HRQOL across population groups but that 
individuals with lower socioeconomic status reported a worse HRQOL than their health state 
alone warranted99 
Nyirenda et al. translated three instruments, namely the W.H.O. Disability Assessment Schedule 
(WHODAS), W.H.O. QOL score (WHOQOL) and Health State Score (HSS) adapted from the World 
Health Organization Study on global ageing and adult health from English to Zulu in an attempt to 
examine health and well-being of HIV infected patients. They back-translated the questionnaires 
before administering them and found that useful information on QOL could be obtained from 
these adapted questionnaires. They also found gender, education level and socioeconomic status 
to be strongly associated with HRQOL101.  
The table below summarises studies which recently translated international questionnaire to 
South African languages. 
Table 3: International questionnaires translated in South Africa 




FACT –B  
Cancers  Pedi 
Tswana 
Zulu 




EQ-5D Variety  Xhosa Need for more rigorous translation and validity testing 






HIV  Zulu Female gender and increasing age associated with 
poorer QOL 
FACT –G – Functional Assessment of Cancer Therapy – General  FACT –B – Functional Assessment of Cancer Therapy 
– Breast 
EQ-5D – European Quality of life 5 Dimensions questionnaire WHODAS – World Health Organization Disability Assessment 
Schedule 




These studies demonstrated the successful adaptation of tools developed in the first world to 
third world countries. They highlight the differences in perception of HRQOL among different 
socioeconomic and cultural communities. It should be kept in mind that the cross-cultural 
validation process is a complex one and that the need for this process could be considered an 
inherent weakness in QOL research in South Africa. The comparison and interpretation of QOL 
instruments across different countries is inconsistent making careful selection of the appropriate 
instrument a key aspect of QOL research102, 103. Finally, there is a need for more QOL instruments 




Clinicians are recognizing the importance of measuring HRQOL in the holistic management of 
patients. Evidence supporting the importance of QOL as an assessment tool and treatment 
outcome is mounting. There is a dearth of literature regarding HRQOL from South Africa and 
Africa and no tool exists to measure HRQOL related to dysphagia in the South African context. 







Chapter 3: Study Aims 
 
 
The aim of this study was to develop a symptom-specific quality of life questionnaire for dysphagia 
that is relevant to our local population. The questionnaire should have the following properties: 
 It should be easy and simple to complete. 
 It should adequately assess the quality of life of our patients.  
 It should be possible to assess the impact of different treatment options on the quality of 
life of patients.  
 The questions should highlight issues that are important to our patients.  
 The questions should be easily understood and not contain terms which are foreign to our 
patient population.  
 It should be possible to use the questionnaire with patients without formal education. 
The first hypothesis to be tested is that the results of the newly developed questionnaire, which 
will be known as the Greys Dysphagia Quality Of Life (GREYS DQOL) questionnaire, correlate well 
with existing tools.  
The specific objective is to determine the cut off points in the South African questionnaire scores 
that optimise sensitivity and specificity of predicting poor quality of life according to the gold 
standard. The gold standard in this case will be two other questionnaires, namely; 
 The Short-Form 36 (SF-36) survey which is a validated generic QOL questionnaire.  
 The dysphagia score which is an internationally used dysphagia scale.   
The second hypothesis is that patients are more likely to complete the South African 
questionnaire than the international ones because they understand the questions better. 
The result of achieving these goals would be a symptom-specific QOL tool for dysphagia that 
addresses the short-comings of similar tools available today. These shortcomings include: 
 Questions that lack relevance to our local population. 
 Lack of ability to assess overall QOL in patients with dysphagia comprehensively. 
 Questions that are difficult to understand by patients with low education levels. 
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Once validated, the newly developed Greys questionnaire can then be used to assess the impact 
of dysphagia as well as the impact of different treatment options on the quality of life of our 
patients.  
The final product would be a comprehensive QOL tool for dysphagia relevant to our local 




Chapter 4: Methods 
 
 
Quality of life measures have become an important part of health outcomes appraisal, particularly 
in population groups suffering from incurable conditions. The majority of QOL instruments 
constructed to date have been developed and validated in a first-world setting, make cross-
cultural comparisons difficult. 
In order to develop a symptom-specific questionnaire that assessed quality of life (QOL) in our 
patients we had to overcome a number of difficulties. The first difficulty was defining what we 
were trying to measure. Health-related QOL (HRQOL) is a qualitative variable which is broad with 
multiple facets and giving it a quantitative value is challenging in itself. There are a number of 
definitions of QOL in the literature encompassing a wide variety of aspects of life other than 
health, including politics, economics and religion.  The World Health Organization (W.H.O) 
definition of QOL states that it is ‘the individuals' perception of their position in life in the context 
of culture and value systems in which they live and in relation to their goals, expectations, 
standards and concerns’37. This definition emphasises the subjective nature of this entity. It is a 
multidimensional concept necessitating the assessment of a number of domains to derive a 
comprehensive view of a person's QOL. Positive as well as negative aspects of life need to be 
included QOL assessments. The broad appeal of the definition of QOL results in richness of 
interpretation, but simultaneously makes it difficult to use in a scientific setting 43, 104, 105. In this 
study we measured health-related QOL (HRQOL) which pertains to the effect of illness and 
treatment on QOL. 
Another difficulty we faced when formulating this study was the issue of validation. Validation is 
considered a key psychometric property of any QOL instrument. It examines whether a 
questionnaire is measuring what it intends to measure. Validation is the process by which any 
data collection instrument, including questionnaires, is assessed for its dependability. Validating 
questionnaires is somewhat challenging as they usually evaluate subjective measures, which 
means they can be influenced by a range of factors that are hard to control. It is an indication of 
the degree to which a questionnaire reflects reality27. In this study we are faced with the challenge 
of validating a questionnaire where no gold standard exists. This is because the questions are 
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relevant to our local population and regards QOL aspects related to dysphagia. No such 
questionnaire exists. 
We chose two existing questionnaire to be administered in concordance with our questionnaire, 
namely the short-form 36 (SF-36) and the Dysphagia Score. The SF-36 was chosen because it is a 
generic QOL questionnaire which is well validated and widely used. Translated versions were 
validated before for use in South Africa106 
The dysphagia score is symptom-specific to dysphagia, like the proposed questionnaire. It explores 
two aspects of dysphagia namely the frequency and severity. An overall score is then given to the 
patient. The biggest advantage of the Dysphagia Score is its brevity. It fails, however, to give a 
comprehensive assessment of QOL. 
The questions formulated would then incorporate similar questions to those used in the existing 
ones in order to compare the responses of the patients to the different questionnaires. 
 
4.1 Formulating the questions for the new questionnaire 
 
 
The formulation of questions for use in a questionnaire is a complex process which is largely a 
matter of subjective judgement. The description of a given life domain becomes so much more 
rigid when expressed through a specific question that the result is a loss of richness of 
interpretation104.  Methods used to generate items for complex measurement scales like QOL 
questionnaires are heterogeneous and there is a lack of guidelines in the literature on how it 
should be done107. 
A questionnaire was compiled consisting of 25 questions which the patients would answer using a 
visual analogue scale. The questions were compiled by the main author and supervisor who 
together had substantial experience in assessing and managing patients in the same population 
group with dysphagia and therefore were aware of the main problems these patients had. The 
questions assessed the following; 
a) The symptom of dysphagia, 
b) Other symptoms related to conditions that commonly causes dysphagia, e.g. 
odynophagia, heartburn, regurgitation, and 




The first eight questions are as follows: 
1) How often do you experience difficulty with swallowing liquids?  
2) How often do you experience difficulty with swallowing soft foods? 
3) How often do you experience difficulty with swallowing raw hard fruits? 
4) How often do you experience difficulty with swallowing meat? 
5) How bad is your difficulty in swallowing when swallowing liquids?   
6) How bad is your difficulty in swallowing when swallowing soft foods?   
7) How bad is your difficulty in swallowing when swallowing raw hard fruit?   
8) How bad is your difficulty in swallowing when swallowing meat?   
 
These questions assess the symptom of dysphagia in detail. Like the dysphagia score to which it is 
being compared it explores the frequency and severity of dysphagia. Unlike the dysphagia score, it 
discriminates between the different food groups starting with frequency and severity to 
swallowing liquids, then moving on to soft foods and hard foods and finally asking about meat. 
There are a number of reasons for this discrimination. Firstly, it gives an indication of the degree 
of dysphagia the patient suffers. A patient who has trouble with swallowing liquids as well as 
solids is much worse off than someone who can swallow liquids but struggles with solid food. This 
in turn will translate into a poorer quality of life. Some patients are able to adjust their diet 
according to their ability to swallow. They may therefore not experience any deficiency in QOL, 
whereas they still have a problem with swallowing certain foods. Many patients are heavily reliant 
on soft foods which form a large part of their staple diet. They will then show a poorer score when 
specifically asked about their ability to swallow soft foods, giving us a better idea of the impact on 
quality of life. For other patients the inability or difficulty in swallowing meat severely affects their 
QOL. These differences will be ascertained when administering these questions to the diverse 
cultural groups we serve.  
These eight questions were compiled using the dysphagia score as a guide and answers to them 




The following eight questions are: 
9) How often do you experience pain when swallowing liquids? 
10) How often do you experience pain when swallowing soft foods? 
11) How often do you experience pain when swallowing raw hard fruits? 
12) How often do you experience pain when swallowing meat? 
13) How bad is your pain on swallowing when swallowing liquids?   
14) How bad is your pain on swallowing when swallowing soft foods?   
15) How bad is your pain on swallowing when swallowing raw hard fruit?   
16) How bad is your pain on swallowing when swallowing meat?   
 
They explore the symptom of odynophagia in as much detail as dysphagia is being explored. The 
reason for this is two-fold. Firstly, odynophagia which means painful swallowing is related to many 
conditions which commonly cause dysphagia and will have an obvious impact on QOL. Secondly, 
many patients are unable to discriminate between dysphagia and odynophagia. They may be 
experiencing dysphagia but perceive it as odynophagia. This will not be picked up if these 
questions are not asked. These questions were not guided by either of the existing questionnaires. 
The next six questions are: 
17) How often do you get chest pain after eating? 
18) How severe is your chest pain after eating? 
19) How often do you experience heartburn? 
20) How severe is your heartburn? 
21) How often do you experience regurgitation (food returning to your mouth after 
swallowing)? 
22) How much weight have you lost since being ill? 
 
These questions ask about other symptoms that may occur in patients with conditions that cause 
dysphagia, viz. heartburn, regurgitation, chest pain and weight loss. They are explored because 
these symptoms will also affect QOL and sometimes the impact may be worse than that of 
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dysphagia. Omitting them may result in missing important factors affecting the QOL of these 
patients. Weight loss is a factor that affects general QOL since it is a distressing symptom to many 
of our patients. Like the previous eight questions, these were not guided by either of the existing 
questions. 
The next two questions are:  
23) How much has your illness affected your social life? 
24) How much has your illness limited your work? 
 
They explore the limitation to social activity and work. These questions are commonly asked in 
HRQOL questionnaires world-wide63, 77, 80, 82, 88, 108. These aspects of patients’ lives are often 
ignored by physicians during clinical assessments and their inclusion in the questionnaires will 
provide better understanding of the impact of the symptom or disease process on QOL. 
The last question is: 
25) How satisfied are you with your current state of health? 
This is a general question regarding the patient’s perspective on his or her satisfaction with their 
current state of health. This is important to ask since the information obtained may yield 
surprising results. For example, a patient presenting with dysphagia secondary to cancer of the 
oesophagus may undergo extensive oncological treatment including chemotherapy and 
radiotherapy. This treatment may be palliative rather than curative and the patient may report a 
lower satisfaction with their current health following treatment than they did before treatment. 
This may occur despite a significant oncological response of the tumour to the treatment. This 
could help us review the treatment in other patients with the same condition. 
The last three questions were guided by the SF-36 and answers to them can therefore be 
compared directly to answers to the SF-36. Definitions of all terms used in the questionnaire are 
given at the end of the questionnaire.  
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4.2 Use of the Visual Analogue Scale 
 
The Visual Analogue Scale (VAS) uses horizontal lines, 10 cm long, representing a spectrum from 
very good to very poor. The respondents mark their response on the scale. As this type of scale 
does not contain a limited number of possible responses, the respondents are given greater 
freedom of expression than with other scales104. It is simple to use and easy to understand. It is 
commonly used in studies assessing pain and has been shown to have measurable value 
function109.  
It therefore seemed to be the best choice of scale to use with our patients since many may not 
have formal education and diversity in culture may result misunderstanding of possible answers if 
another scale such as the Lickert scale was used. 
An example of the use of the VAS in the questionnaire is shown below;  
25) How satisfied are you with your current state of health? 
0 (completely satisfied)                                                      10 (completely dissatisfied) 
 ___________________________________________________ 
The terms ‘completely satisfied’ and ‘completely dissatisfied’ are used as a guide on the VAS to 
assist the patient in answering the questions. This will ensure better uniformity when gathering 
data. 
 
4.3 Questionnaire design 
 
The length of the questionnaire was chosen to incorporate both comprehensiveness and brevity. 
We wanted to create a questionnaire that was as comprehensive as possible so as to get an 
understanding of the QOL of the respondent as best as we could. At the same time we wanted to 
avoid a long questionnaire which would prove taxing on patients who may already be frail from 
their disease process. Many of the questions are closely related e.g. the eight questions on 




The questionnaire was designed to be self-administered. However it is possible to complete the 
questionnaire with the help of a health care worker in the event that the patient needs help in 
understanding the questions. This situation would be rare since the questions were specifically 
designed to be simple and straightforward. 
Patients were asked to mark a point on the V.A.S which was 10cm long. A mark out of ten could 
then be given for each question. The lower scores indicated a less severe symptom or better QOL 
while a higher score indicated increased severity of symptoms or poorer QOL. The score of all the 
questions can then be added up and the total out of a maximum of 250 can then be converted to 
a percentage.  Thus, a higher Greys Dysphagia QOL score represented a poorer QOL. 
 
4.4 Choice of international questionnaires 
 
Two international questionnaires were chosen to test validate the GREYS DQOL questionnaire and 
compare the compliance of patients in answering questions from the different questionnaires.  
 
4.4.1 Medical Outcomes Study 36-item Short form health survey (SF-36)  (Appendix 5) 
The Short Form 36 (SF-36) which is a well validated generic QOL questionnaire used commonly 
world-wide. The health concepts explored by the SF-36 are shown below 28. 
 Physical functioning 
 Role limitation due to physical problems 
 Bodily pain 
 General health perceptions 
 Vitality  
 Social functioning 
 Role limitation due to emotional problems 
 Mental health 
 
The SF-36 was constructed to satisfy minimum psychometric standards necessary for group 
comparisons. The eight health concepts were selected from 40 concepts included in the Medical 
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Outcomes Study (MOS). Those chosen represent the most frequently measured concepts in widely 
used health surveys and those most affected by disease and treatment77, 80. The eight health 
concepts are summarised into two summary scales, viz. the physical component summary and the 
mental component summary scales. An overall score can then be given of which the minimum is 0 
and the maximum is 100. The higher the SF-36 score, the better the QOL of the patient.  
The biggest advantage of the SF-36 is that is strikes a good balance between comprehensiveness 
and brevity. Despite this advantage and the fact that it has been fully validated, there are a 
number of problems with using it as a tool to assess QOL in South Africa. It was developed in the 
first-world and many of the questions have either have no relevance to our patients or are poorly 
understood by them. An example is question 9 (see appendix 5) which states: 
9. How much of the time during the past 4 weeks. 
a. Did you feel full of pep? 
b. Have you been a nervous person? 
c. Have you felt so down in the dumps nothing could cheer you up? 
d. Have you felt calm and peaceful? 
e. Did you have a lot of energy? 
f. Have you felt downhearted and blue? 
g. Did you feel worn out? 
h. Have you been a happy person? 
i. Did you feel tired? 
Each of these questions has six possible answers as follows; 
 All of the time 
 Most of the time 
 A good bit of the time 
 Some of the time 
 A little of the time 
 None of the time 
 
The respondent is required to tick a box next to the answer which they feel describes their feeling 
most accurately. Many of our patients would have difficulty in responding to these questions as 
they may not think about their mental state in these terms. They would not necessarily answer 
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these questions using terms like ‘A good bit of the time’. This underscores the fact that HRQOL is 
influenced by culture and perception. 
The SF-36 is designed to be self-administered by the patient. This is how it was administered to all 
literate respondents. For those who could not read, it was administered by an interviewer in the 
presence of the main investigator. The items and scales were constructed for scoring using the 
Likert method of summated ratings. The Likert scale is a psychometric response scale which 
attempts to assess a respondent’s degree of agreement with a statement. It is a popular option 
for questionnaire because of ease of use. The major drawback of its use is the fact that the ideal 
number of response options is not well established and range from two options, usually ‘yes’ or ‘ 
no’ to as many as nine. In the SF-36 there is inconsistency in the number of options available with 
some questions offering two and others six options. Furthermore, some questions require yes-no 
answers, while others assess degree of agreement with a statement and others still have a 
number of different answers. This may lead to confusion on the part of the respondents which is a 
weakness of the SF-36 in our setting.  Analysis and interpretation of the resulting linear scales 
assumes that item scores are linearly related to the underlying health concept being measured77, 
80, 81. 
4.4.2 The Dysphagia Score (Appendix 4) 
The second international questionnaire used in this study is the Dysphagia Score which has not 
been validated but is used internationally specifically for patients with dysphagia58, 89, 90. The 
dysphagia score was used on patients suffering from dysphagia due to achalasia which is a motility 
disorder of the oesophagus which results in incomplete relaxation of the lower oesophageal 
sphincter during swallowing and aperistalsis of the oesophagus. It was shown to have good 
practical application52, 58. The first question asks about frequency of dysphagia and gives five 
options each with a score as seen below; 
       0=never 1=<1d/week 2=1d/week 3=2-3d/week 4=4-6d/week 5=daily 
The second question asks about the severity of dysphagia and also has five possible options as 
seen below; 
       0=none 1=very mild 2=mild 3=moderate 4=mod. severe 5=severe 
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The respondent is required to tick whichever box closely reflects the frequency and severity of 
their symptom. A higher dysphagia score indicated increased severity of symptoms. This 
questionnaire fails to assess overall HRQOL as it only explores one symptom. 
The GREYS DQOL score aims to be a HRQOL questionnaire which is symptom specific to dysphagia. 
It is for this reason the two international questionnaires were chosen as comparisons. 
 
4.5 Demographic data 
 




Once the questions were compiled, the questionnaire, together with the SF-36 and the Dysphagia 
score questionnaire was sent to the language department at the University of Kwazulu Natal to be 
translated into Zulu. This is because Zulu and English are the 2 most common home languages in 




The study was performed at Greys Hospital which is a tertiary hospital in KwaZulu-Natal. The 
hospital manages patients from the Pietermaritzburg metropolitan area as well as patients 
referred from surrounding district and regional hospitals and distant hospitals falling within the 




A minimum sample size for statistical significance was not possible to calculate at the beginning of 
the study since the expected differences were not known. Thus the sample size to be used was 
determined from logistical rather than statistical constraints. As this is a Masters degree study, a 
single year of data collection of approximately 100 patients would be sufficient to calculate initial 
statistical significance and power. 
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Patients presenting to our surgical department with dysphagia as their main complaint between 
May 2010 and April 2011 were entered into the study. The questionnaires were completed prior 
to treatment. The majority of patients presenting with dysphagia to our surgical department 
suffer from oesophageal cancer. Informed consent was obtained and an information document 
describing the details of the study was given to the patients. All patients were adults aged 18 
years and older. The patients were asked to complete all three questionnaires. The V.A.S was 
explained to the patient and examples were given when needed. Similarly the method of 
answering the two international questionnaires was also explained to each patient. This was done 
by the main investigator with the help of an interpreter when needed.  Patients were asked to 
answer all questions that they understood as truthfully as possible. The questionnaires were self-
administered in English and Zulu. Patients who could not read had the questions read out to them 
by a nurse fluent in Zulu in the presence of the main investigator. This was only needed with Zulu-
speaking patients. They were asked to indicate their answer on the VAS and asked to give their 
answers to the other questionnaires verbally to the person helping them. The option indicated by 
the patient was then ticked. This was also done by the main investigator with the help of an 
interpreter. Patients were allowed to ask clarification on any questions which they did not fully 
understand. If they still did not understand the explanation then they were told to skip the 
questions. Any questions that that were not understood or that the patient thought to have no 
relevance to their lives could be skipped. Different interpreters were used for different patients 
and none were trained in administering the questionnaire. The main investigator was therefore 
present at each administration.   After completion, questionnaires were collected and filed.  
 
4.9 Data collection 
 
Once 100 questionnaires were completed the questionnaires were scored. The GREYS DQOL 
questionnaire was scored by measuring the point indicated on the VAS by the patient. The scores 
were added up and the final score given as a percentage. The SF-36 was scored using software 
obtained from the internet (www.nephrology.rei.edu/qol.htm).  The same program was used to 
score SF-36 QOL in haemodialysis patients110. A physical component summary, mental component 
summary and overall final score out of 100 was obtained. The two components of the dysphagia 
score were added up to give a final score out of 10. The compliance of each patient in answering 
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the different questions was also measured. The level of education was divided into 3 groups and 
defined as follows: 
1 - No formal education received 
2 - Some formal education received but did not finish school to matriculation level 
3 - Completed school to matriculation level  
 
The final scores of each questionnaire were entered onto an Excel spread sheet and the data was 
analysed.  
4.10 Data analysis 
 
The scores of the patients, which indicated their symptom severity as well as their QOL were 
analysed. The scores of the three questionnaires were compared using Spearman correlation 
analysis. We used univariate and multivariate regression analysis to assess the relationship 
between age, gender, level of education and each of the three questionnaires.  
We performed a chi squared to compare compliance of patients in answering the questions in the 
three questionnaires. We defined compliance by the number of questionnaires filled out 
completely. Thus, all questionnaires which were completed without the omission of a single 
question were counted against those which were incomplete. Compliance was looked at in order 
to assess whether patients were more likely to answer questions from the newly compiled 
questionnaire compared to the established questionnaires. 






Chapter 5: Results 
 
 
The aim of this research was to design and assess a new questionnaire which could be used in the 
South African context to assess the quality of life (QOL) experienced by patients experiencing 
dysphagia. The new questionnaire was based on questions from two others, one generic and one 
specific to dysphagia, which are used internationally. We added questions which were 
contextualised to give us more information about the patients in our setting.  We exposed our 
sample to these two internationally recognised quality of life questionnaires as well as to the 
newly developed questionnaire which we developed. Patients had an option to complete the 
questionnaire in one of two languages, English or Zulu, which is the language most commonly 
spoken in KwaZulu-Natal.  
In this chapter we provide basic demographic data of our sample, look at the compliance rates of 
questionnaire completion for the new and two internationally recognised questionnaires, and 
compare the results of the three tests in terms of the QOL score given by each patient. Each of 
these aspects of the data is dealt with separately below. 
 
5.1 Questionnaire development 
 
The newly developed questionnaire is named the Greys Dysphagia Quality Of life (GREYS DQOL) 
questionnaire. It consists of 25 questions exploring the symptom of dysphagia and its effects on 




5.2.1 Gender distribution 




5.2.2 Age distribution 
Two patients did not provide their age; the average age was worked out for n = 98 giving the 
mean age as 59 years (range 18-101, interquartile range 52-71). The box whisker plot below shows 
the age range to be wide with almost half the patients being in their 6th and 7th decade of life. 
Raw data is available in Appendix. 
 
Figure 1: Box whisker plot for age of study population (n= 98) 
5.2.3 Diagnosis 
While the final diagnosis was not available for the majority of patients, it was known in 26 patients 
and of these 17 had malignant obstruction of the oesophagus. 
5.2.4 Language preference 
Half the respondents chose to answer the questionnaire in English while the other half opted to 
answer the questionnaire in Zulu.  
 
5.3 Level of education 
 
The level of education was obtained from 88 patients. Of the average grade completed at school 
was Grade 5 (five years of primary school education). Only three respondents received some form 
of tertiary education. Eleven patients completed school to matriculation level. Twenty three 
respondents received no formal schooling at all. Table 4 illustrates the level of education obtained 





Table 4: Level of education of sample population 
Level of Education Frequency Percentage Cumulative 
percentage 
1 -  no formal education 23 26 26 
2 – Some formal education, did not complete 
school 
54 61 87 
3 – completed school to matriculation level 11 13 100 
Total 88 100  
 
 
5.4 The QOL of our patients 
 
Appendix 1 compares the results of the three questionnaires. The GREYS DQOL and the SF-36 are 
both scored out of 100 while the dysphagia score is scored out of 10. The mean score for patients 
on the GREYS DQOL questionnaire was 61 where a score of 0 indicates the best quality of life 
possible and a score of 100 indicates the worst quality of life possible. The mean score for patients 
on the SF 36 was 30, where 0 indicates the worst possible quality of life and 100 the best possible 
quality of life. The mean score for patients on the dysphagia score was 7, where 0 is the best score 
and 10 the worst. The results show a poor QOL for all three questionnaires with scores closer to 
the worst QOL than the best QOL. 
 
5.5 Comparison of scores 
  
The scores of the three questionnaires were compared. In order to compare the three instruments 
in the same direction, the SF-36 scores were inverted so that the highest score was worse than the 
lowest score. This was achieved by subtracting the score from 100 and using the difference. The 
DS score was multiplied by 10 so that all three scores could be compared as a total of 100. The box 




Figure 2: Comparison of scores from the three questionnaires 
Table 5: Descriptive statistics for each questionnaire 
 
 
While the quality of life scores for the patients were all closer to poorer quality of life than to the 
best possible quality of life for all three questionnaires, the GREYS DQOL questionnaire showed a 
wider variation in the scores. 
 
  
Labels GREYS DQOL SF-36 DS 
Min 3 1 0 
Q1 42 57.25 67.5 
Median 65 75.5 95 
Q3 77 81.25 100 
Max 100 86 100 
IQR 35 24 32.5 
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5.6 Correlations  
 
The newly compiled Greys Dysphagia Quality Of life (GREYS DQOL) questionnaire score correlated 
moderately with both the SF-36 and the Dysphagia Score. The results of the Spearman correlation 
are shown in the scatter plots below. 
 
                                            R = 0.29 
Figure 3 : Scatter plot showing correlation between GREYS DQOL and SF-36 questionnaires 
 
                                      R = 0.30 




5.7 Compliance  
 
Questions 1-8 of the GREYS DQOL questionnaire were designed to get the same information from 
the patient as that from the Dysphagia Score’s two questions. Whilst there was no statistically 
significant difference between the completion rates of the two questionnaires (chi-square =1.008, 
p = 0.315) there are some differences in the way each questionnaire was answered. All patients 
attempted at least some of the GREYS DQOL questions while 13 patients did not answer either of 
the Dysphagia Score questions. Two patients answered under half of the GREYS DQOL questions in 
this section. Four patients left out one of the Dysphagia Score questions. 
Questions 22 – 25 of the GREYS DQOL questionnaire were designed to get the same information 
as the SF-36 questionnaire. The GREYS DQOL had a better compliance for these questions than the 
SF-36 with 92% of the patients answering all the questions in the GREYS DQOL and only 57% of 
them answering the entire SF-36 questionnaire (Chi-square 32.4, p<0.01).  
Both the GREYS DQOL and the SF-36 questionnaires are long questionnaires. Their relative length 
could affect the compliance. Comparing the compliance of the entire GREYS DQOL questionnaire 
with that of the entire SF-36 it is found that patients were more compliant with the GREYS DQOL 
questionnaire than the SF-36 (chi-square 4.253 p=0.039). When looking at the overall percentage 
of questions answered per questionnaire, however, the results were similar between the three 
questionnaires (see Appendix 2). 
5.8 Relationship between the questionnaires and age, gender and level of education  
(see Appendices 10 to 18) 
Univariate analysis showed that age and gender had no influence on QOL score for each of the 
three questionnaires. Level of education had no influence on QOL scores for the GREYS DQOL and 
DS questionnaires. The score of the SF-36 was, however, influenced by level of education. 
Multivariate regression analysis showed that the GREYS DQOL questionnaire score was not 
influenced age, gender or level of education (Table 6). The SF-36 score was influenced by age and 
more importantly, level of education making it a less appropriate tool for population groups with 





Table 6: Multivariate regression analysis of GREYS DQOL vs. SF-36 reciprocal, DS, age, gender and 
level of education (significant results are highlighted in bold).   
GREYS DQOL Coeff Std err t p>[t] 95% CI 
SF-36 reciprocal 0.53 0.12 4.23 0.000 0.28-0.78 
DS 2.27 0.63 3.59 0.001 1.01-3.53 
Age -0.12 0.16 -0.73 0.46 -0.45-0.21 
Gender 3.54 4.44 0.80 0.42 -5.3-12.39 
Level of education 3.08 3.82 0.81 0.42 -4.52-10.69 
Cons 5.36 17.52 0.31 0.76 -29.49-40.23 
 
Table 7: Multivariate regression analysis of SF-36 reciprocal vs. GREYS DQOL, DS, age, gender and 
level of education (significant results are highlighted in bold).  
SF-36 reciprocal Coeff Std err t p>[t] 95% CI 
GREYS DQOL 0.33 0.07 4.23 0.000 0.17-0.49 
DS -1.08 0.52 -2.05 0.04 -2.13- -0.03 
Age 0.38 0.12 3.06 0.003 0.13-0.63 
Gender 1.99 3.54 0.56 0.57 -5.06-9.05 
Level of education -7.17 2.95 -2.43 0.01 -13.05- -1.30 
Cons 43.90 13.09 3.35 0.001 17.85-69.96 
 
5.9 Summary of results 
 
In summary, the overall QOL of our patients was found to be poor. The GREYS DQOL correlated 
well with the international questionnaires while demonstrating superior compliance. The level of 
education of our patients is low and while this did not influence the score of the GREYS DQOL 






Chapter 6: Discussion and Conclusions 
 
 
The impact of dysphagia on QOL is largely reflected by clinician-based assumption rather than 
input from patients and the most dysphagia literature focus on physiological assessment of 
swallowing function3, 34, 88. There is a need to gain knowledge about the patients’ perspective 
regarding the impact of dysphagia on their QOL. As clinicians we are too reliant on anatomical and 
functional assessments and often forget about the patient and what they wanted when they 
decided to seek help in the first place. While clinical, laboratory and radiological assessments 
provide valuable information about the disease, it is impossible to separate the disease from an 
individual’s personal, psychological and social context.  
QOL assessments are often accepted as outcome measures in clinical research but are rarely used 
in routine clinical practice. The reasons for this hesitancy to use QOL instruments in the clinical 
setting are multifactorial and include the conceptual vagueness of QOL, the lack of awareness 
about the importance of QOL, time and resources required to implement these instruments and 
the paucity of fully validated, relevant and contextualised questionnaires111, 112. QOL measures 
have a number of potential uses in clinical practice. They can be used to prioritise problems, 
facilitate communication, identify preferences and monitor response to treatment113. Patients’ 
satisfaction with treatment depends largely on relief of symptoms as well as the experience and 
quality of treatment given59. QOL assessment should therefore be part of routine clinical practice.  
While there are a number of generic and specific QOL assessment tools available in the literature, 
they were all developed in the first world setting and lack relevance when it comes to our local 
population28.  
We therefore set out to develop a questionnaire specifically assessing dysphagia related QOL and 
compared it to questionnaires that have been used in the literature. The questionnaire was 
designed to contain questions that have relevance to and are more easily understood by our local 
population. To our knowledge, no such questionnaire exists and we therefore have no tools with 
which to examine the true impact of dysphagia on the QOL of our patients. The newly developed 
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questionnaire could also be used to assess patient reported outcomes after treatment is 
administered for dysphagia thereby assisting in adapting existing protocols designed in the first 
world to the third-world setting. 
 
6.1 Developing the questionnaire 
 
We aimed to develop a new questionnaire with the following characteristics: 
 It had to be symptom-specific to dysphagia. 
 It had to include aspects of general QOL issues.  
 The questions needed to have relevance to our patient population. 
 The questions needed to be easily understood by our population. 
 The questionnaire needed to be easy and simple enough to be completed by individuals 
without any formal education. 
 The questionnaire needed to strike the right balance between assessing the full effect of 
dysphagia on QOL and being brief enough so as to avoid being tedious and time-
consuming.  
 
These aims were challenging since no gold standard exists for what we are trying to achieve. The 
newly designed questionnaire contains a combination of questions related to the symptom of 
dysphagia as well as QOL issues. There are a number of questions relating to dysphagia itself. The 
reason for this is that the QOL of patients will be affected differently depending on the degree and 
frequency of dysphagia and we chose to explore this in great detail in the questionnaire. 
Dysphagia to different types of foods, e.g. liquids, soft foods, meat, etc. is measured  separately 
since some patients may not have access to all types of food due to social circumstances. A 
patient who only eats soft foods and has no access to meat or nutritional liquid feeds will, for 
example feel the impact of dysphagia to soft food to a much greater extent than someone who 
has access to all types of food. Conversely, the relief of dysphagia of a specific food type may have 
significant effects on QOL of some patients.  Odynophagia is explored in similar detail since many 
of our patients are unable to differentiate odynophagia from dysphagia.  
Symptoms associated with dysphagia like regurgitation, heartburn and chest pain occur commonly 
in conditions that cause dysphagia and for this reason questions regarding these symptoms are 
asked in the questionnaire. If ignored, the potentially important impact on QOL of these 
associated symptoms will be missed. Treatment aimed at relieving these symptoms could 
significantly impact on QOL since many patients use symptom relief to describe treatment 
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satisfaction. There is a strong relationship between symptom relief, health-related QOL and 
treatment satisfaction84. Many conditions presenting with dysphagia causes significant weight 
loss. The symptom of weight loss has many implications which may differ from patient to patient. 
For many, it is a distressing symptom indicating a poor prognosis. This will lead to feelings of 
anxiety and depression114. For other patients, the weight loss may not even be noticed until a 
significant amount of weight is lost and the symptom itself may have little impact on QOL. 
Significant weight loss is directly linked to malnutrition and malnutrition significantly affects 
patients’ QOL and prognosis115. 
The last three questions in the questionnaire pertain to general QOL issues. The first explores 
limitation in social functioning. This question was chosen to cover the mental component of QOL 
since social functioning has been shown to be significantly affected by dysphagia and is considered 
part of the mental component of QOL in literature7, 47. The impact on social activity may be related 
to feelings of anxiety and depression which are associated with dysphagia. The question on 
limitation of work in turn covers the physical component of QOL as dysphagia has been shown to 
have a significant impact on physical functioning47. The final question is a general one enquiring 
about satisfaction general state of health. This gives us information from the patient’s perspective 
which is an important aspect of measuring Health-related QOL. It will help to differentiate 
between patients who respond differently to a physical or mental limitation as well as effects of 




The results of the demographics in this study reflect the typical population that would suffer from 
dysphagia. The majority were male with an advanced mean age of 59. This is the typical patient 
profile of oesophageal malignancy which is a common diagnosis among our patients presenting 
with dysphagia. Cancer of the Oesophagus is a common malignancy in South Africa ranking in the 
top ten non-skin cancers among men and women (www.cansa.org.za). This disease is more 
common in males and in older patients, a fact which coincides with our patient demographics. 
These findings were supported by Mannell and Murray who reviewed 1926 cases of oesophageal 
cancer in South Africa and found that 1438 of these patients were male resulting in a male to 
female ratio of 3:1 and that the average age was 56 years. They stated that the typical South 
African patient with oesophageal cancer is a man 56 years of age and that the most common form 
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of treatment was palliative116.  The diagnosis was unknown in the majority of patients because the 
questionnaires were administered to the patients on first presentation before any special 
investigations were performed to confirm the diagnosis. 
The gender distribution of our sample population may have had an impact on the results of our 
study. The majority of our patients were male and in certain cultures men are less likely to 
complain about anything as there is an impression that complaining is a sign of weakness. This 
may be a reason why, in the general population, self-rated QOL scores tend to be lower in females 
than males117, 118. These factors may potentially skew results of QOL studies. This was not found in 
our study as gender had no influence on QOL life scores. The World Health Organisation QOL 
group’s definition of QOL as “an individual’s perceptions of their position in life, in the context of 
the culture and value systems in which they live, and in relation to their goals, expectations, 
standards and concerns”  underscores the importance of cultural differences in QOL 
assessments39. Indeed, studies have found significant differences in perceived health status 
among patients of different socio-demographic backgrounds. Factors affecting patients’ perceived 
health status include gender, age, education level, social relationships, presence of medical 
problems, race or ethnic group, socio-economic and employment status117. Manuti et al. assessed 
HRQOL of patients in one of the poorest areas of Italy using the SF-36 and found that the patients 
from this area had a poor HRQOL and that this perception was even poorer in subgroups of the 
population, according to several socio-demographic, clinical characteristics, and behavioural risk 
factors119.  
Exactly 50% of the patients opted to respond to the questionnaires in Zulu. Translation of QOL 
questionnaires has been an important methodological step in the expansion of cross-cultural 
research. Many instruments, including the SF-36 have undergone translation from the source 
questionnaire in English to a number of other languages. These translation efforts have mainly 
focused on European and Asian languages and have neglected African languages. Mullin et al. 
showed acceptable internal consistency when translating the English Functional assessment of 
cancer therapy questionnaire to three African languages and concluded that further research in 
this area is warranted98. The SF-36 has been used and translated in the South African setting 




6.3 Level of education 
 
The level of education of our patients is an important consideration in the interpretation of the 
results of our study. The overall level of education was low with up to a quarter of our patients 
being without any formal education at all and only 12.5% of patients completing school. Education 
and income has been shown to affect SF-36 scores118. Measurement scoring is particularly 
problematic when using outcome instruments developed in the first world due to literacy 
deficiency in our country. The focus of these instruments is usually on self-completion 
questionnaires19. 
 A low level of education is associated with limited health literacy. Health literacy is the ability to 
obtain, process, and understand health information to make appropriate health decisions.  
Patients with limited health literacy may have difficulty understanding written medical 
information, communicating with healthcare providers, and navigating complex healthcare 
systems. Studies in various patient populations demonstrate an association of limited health 
literacy with poorer health-related knowledge and poorer health status109.  
While QOL may be considered a universal concept, differences in age and gender as well as 
cultural differences will play a role in its measurement. Cultural background, socioeconomic 
status, educational level, and gender interact in the development of symptom or disease-related 
beliefs that affect patient concerns, anxieties and expectations from the health care process120. Of 
these factors, level of education played a significant role in this study. 
 
6.4 The quality of life of our patients 
 
The impact of dysphagia on QOL has been studied and found to be significant2, 8, 34, 52-58.  It is one 
of the most distressing symptoms in patients with cancer-related oesophageal obstruction93. The 
ability to measure this impact is important; especially since the majority of patients presenting to 
our surgical department with conditions causing dysphagia will be subjected to palliative 
treatment. Quality of life is an important factor in the assessment of effectiveness of different 
treatment options in these circumstances. The score of the patients in each questionnaire indicate 
an overall poor QOL. In the study by Munati et al.119 the overall QOL was also found to be poor 
among their patients. Yet the mean SF-36 score was 45. In our study it was 30, reflecting the 
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severity of the impact of dysphagia on QOL of our patients. The results of the GREYS DQOL 
questionnaire concur with those of the SF-36 and the results of the dysphagia score indicate high 
severity of the symptom. There is no doubt that treatment should be aimed at improving this and 
that it should not impact negatively on QOL. Assessing the QOL before and after treatment would 
therefore be invaluable. 
There is evidence that overall QOL significantly predicts survival in patients with advanced 
malignancy, making it a useful prognostic indicator. Changes in QOL scores after treatment for 
cancer have also been found to be prognostically important, where improvements in physical 
well-being, mood, and pain scores significantly predicted longer survival121. Mortality is also high 
in patients with swallowing difficulty, with advance age being one of the independent predictors 
of mortality in this group of patients121. The results in this study therefore portend a poor 
prognosis for our patients. 
 
6.5 Comparisons of scores 
 
The GREYS DQOL showed a wider variation in scores compared to the other two questionnaires. It 
is not expected that the DS would show a wide variation because it consists of only 2 questions. It 
only explores the symptom of dysphagia. The impact of additional symptoms on QOL is not 




In order to test for validity, correlation between the GREYS DQOL questionnaire and the other two 
questionnaires was assessed. Validation is a process by which a data collection instrument is 
tested for dependability. It is often defined as the extent to which an instrument measures what it 
intends to measure61. Validating our questionnaire would be a difficult process since there is no 
gold standard to compare it to. While there are a number of QOL questionnaires available in the 
literature, the majority of them contain questions that have little relevance to our patients. The 
newly compiled questionnaire score correlated moderately with both the SF 36 as well as the 
dysphagia score on the Spearman correlation. This therefore confirms the validity of the GREYS 
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DQOL questionnaire through test validity. The SF-36 questionnaire was chosen because of its 
widespread use in the literature as well as the fact that it is validated internationally and in South 
Africa77, 78, 80, 81, 106. The relationship between the SF-36 and the dysphagia score is consistent with 
that of Youssef et al. who performed a similar study, but only included patients who had 
undergone laparoscopic Heller myotomy for achalasia in their study. They assessed QOL using the 
SF-36 and dysphagia by using the same dysphagia score used in our study. They found that the 
dysphagia score was inversely correlated with total the SF-36 score58.  
The new questionnaire addresses the shortcomings of the other two questionnaires used. The 
questions are more relevant to our patients than those in the Sf-36 and it explores QOL in more 




We defined compliance as the number of questionnaires filled out completely. The GREYS DQOL 
showed higher compliance when compared to the SF-36 and the dysphagia score.  In order to 
obtain an accurate assessment of the impact of dysphagia on the QOL, patients would have to 
answer all the questions in each questionnaire. Any questions that are omitted will contribute to 
weakening the accuracy of the assessment. One of the problems of using internationally 
recognized questionnaires to assess the QOL of our patients is that many of the questions have no 
relevance to the patients. For example, asking about a round of golf, which is a question in the SF-
36 questionnaire, has no relevance to someone who has not been exposed to golf as a sport. 
Many of our patients fall into that category. While designing the GREYS DQOL questionnaire, the 
patient profile of the area that we serve was taken into account. Taking into account the low level 
of education of our patient population it would therefore be a reasonable assumption that the 
majority of our patients are more concerned about basic human needs such as being able to work 
than they are about playing golf for example.  
The reason for the higher compliance rate is possibly because of cultural differences between our 
population group and those tested in the internationally recognised questionnaires. We tried to 
overcome this difficulty with the development of a local questionnaire. The questions attempt to 
view the problem from the patients’ perspective by taking into account the culture of the patients. 
Culture is defined as the ‘integrated patterns of human knowledge beliefs and behaviour’122. It 
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includes a number of aspects including art, tastes, ceremonies, rituals and institutions such as 
marriage in a given community. Health attitudes, beliefs and behaviour are products of culture. 
While there are several projects which translate standardised QOL measures for use in different 
cultural setting, these projects have tended to be concerned mostly with the languages of Europe 
and North America39. Cross-cultural validation of these instruments would therefore be needed in 
order to use them locally. This translation and adaptation process is important because the way 
the constructs such as participation, disability and health-related quality of life are understood in 
different cultures may vary and it cannot be assumed that instruments to assess QOL are cross-
culturally valid39, 43, 123.  Stevelink and van Brackel reviewed the extent to which insights in cultural 
equivalence testing have been applied to different HRQOL instruments the majority of the 
instruments received minimal rating for the categories of cultural equivalence. They defined 
cultural equivalence as ‘the extent to which an instrument is equally suitable for use in two or 
more cultures’124. The internationally validated questionnaires do not have cross-cultural validity 
and this is the main reason for the inferior compliance in completing them.  
 
6.8 Relationship between the questionnaires and age, gender and level of education 
 
The scores of the GREYS DQOL and DS was not influenced by age, gender or level of education on 
univariate and multivariate analysis while the SF-36 was influenced by level of education on both 
univariate and multivariate analysis. This is a significant finding since the overall level of education 
of our study population was low. It means that the GREYS DQOL questionnaire is a more suitable 
tool for QOL assessment in our population than the SF-36. A possible reason for this finding is the 
fact that the GREYS DQOL was developed locally by investigators with extensive experience in 
working with the local population. Respondents may find it easier to relate to the questions. 
Another possible reason is the use of the visual analogue scale as opposed to the Lickert scale. It 
has been shown that locally developed questionnaires as well as questionnaires with more visual 
options are more accurate than internationally developed and validated questionnaires in 
assessing QOL in individuals with lower literacy levels117, 125  
6.9 Relevance 
 
This study is based on the assumption that the South African questionnaire is more relevant to our 
local population. This assumption is valid since it was designed in KwaZulu Natal in South Africa 
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which is the same area that the patients live as opposed to the other two questionnaires that 
were designed in the first world. Furthermore, the questions were formulated by the main 
investigator and supervisor who together have extensive experience with patients presenting with 
dysphagia as their main complaint. Studies looking at QOL that are undertaken in different 
countries are expected to show divergences since health QOL is also modulated by cultural and 
care patterns29. Using a locally designed questionnaire would therefore give clinicians a more 
accurate assessment of the impact of dysphagia on the QOL of patients from the same area. The 
effectiveness of different treatment options could also be assessed more accurately. 
 
6.10 Limitations of this study 
 
The main limitation of this study is the difficulty in validating a newly designed questionnaire 
where no gold standard exists. This is an unavoidable limitation since it is the first study looking 
specifically at the impact of dysphagia on the QOL of patients in a South African setting. It was a 
necessary study since dysphagia is a common presenting complaint in our population and QOL 
studies are not often done on our patients. Previous authors faced with similar problems used 
face validity and content validity in order to validate their instruments. Face validity examines 
whether an instrument appears to be measuring what is intended to measure, and content 
validity examines the extent to which the domain of interest is comprehensively sampled by the 
questions in the instrument. One of the criteria to achieve content validity is to involve the target 
population in the question selection16 and this was not fulfilled. Quantitative testing of face and 
content validity are rarely attempted25. Validity and reliability is difficult to test without a gold 
standard. This problem has been encountered before in the South African context127. Our 
questionnaire did, however, show sufficient correlation with the international ones confirming 
test validity.  
Another limitation of the study is that test-retest reliability was not evaluated for the 
questionnaire. In order for this to be done, the same questionnaires would have to be 
administered to the same patients at different times and this was not done as all patients were 
given all three questionnaires at one setting only. The reason for this is that follow up is very 
difficult in our setting. Many patients are either unwilling or unable to return to hospital for a 
variety of reasons including economic, social and physical limitations. In addition, many patients 
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lack insight into their disease process and fail to return for follow up once they are feeling better. 
Some patients return to health care facilities in closer proximity to their homes for follow up128. 
The level of education of patients and the lack of understanding of the importance of follow up 
also play a role129.  Indeed loss to follow up is one of the most common reasons for inadequate 
treatment of patients in South Africa130. 
The translation process also contributes to the limitations in this study. All three questionnaires 
were directly translated. While experience with translation is still limited, it is suggested in the 
literature that without rigorous back-translation and pretesting, questionnaires may be 
interpreted differently in a new language131. In addition, cultural differences may adversely affect 
an instrument’s measurement properties. Future research should aim to back-translate and 
pretest all three questionnaires and repeat the validation process. 
 
6.11 Future research 
 
Future research should assess the factors affecting compliance of patients in completing the 
questionnaire in more detail and the change in quality of life of patients after receiving treatment 
for dysphagia. The responsiveness of the GREYS DQOL would be tested. The reasons for poor 
compliance in answering questionnaires should be sought. Social and cultural aspects of patient 
care should be taken into account. The results of the completed questionnaires should reflect a 




In conclusion, this study shows that dysphagia does result in a poor quality of life of the affected 
individual and that the Greys Dysphagia QOL questionnaire can be used to assess the impact of 
dysphagia on as well as the impact of different treatment options on the quality of life of patients. 
It is a comprehensive symptom-specific tool which combines generic and dysphagia-specific QOL 
aspects. It is easy to complete with questions that are relevant to our local population and 
suitable for patients with low literacy levels. The treatment options currently used in our setting 
are known to improve dysphagia symptoms but their effect on QOL in our setting is not known 
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and needs to be evaluated. This study provides a simple, effective and locally appropriate tool to 
assess different modalities of therapy for conditions presenting with dysphagia in a developing 
world context. 
This is the first time this is attempted, highlighting the inadequacy of holistic care in our setting. 
Further refinement will make it a tool to assess outcome and predict prognosis and it can then be 
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Appendix 1: Results of scores for each patient 
 
N GREYS 
DQOL SF-36  DS 
1 80 19 10 
2 77 32 9 
3 33 36 10 
4 8 55 6 
5 3 10 4 
6 30 33 10 
7 20 16 5 
8 66 15 10 
9 81 20 0 
10 89 22 5 
11 45 70 0 
12 67 6 0 
13 24 17 10 
14 68 47 9 
15 36 66 6 
16 28 54 6 
17 53 59 9 
18 76 33 7 
19 49 81 10 
20 83 23 10 
21 35 21 0 
22 74 12 8 
23 54 59 6 
24 45 29 10 
25 33 55 7 
26 44 20 10 
27 65 31 0 
28 82 42 10 
29 62 24 10 
30 85 41 10 
31 92 10 10 
32 51 45 8 
33 77 22 10 
34 62 21 10 
35 54 25 0 
XII 
 
36 22 86 3 
37 70 36 9 
38 89 29 10 
39 69 10 10 
40 77 20 10 
41 65 8 10 
42 76 13 10 
43 90 19 10 
44 15 47 2 
45 89 28 9 
46 78 12 2 
47 75 24 0 
48 64 18 0 
49 54 23 2 
50 60 23 0 
51 98 12 5 
52 70 27 10 
53 78 21 9 
54 88 34 10 
55 79 36 0 
56 97 25 10 
57 95 19 9 
58 98 29 9 
59 100 23 10 
60 58 57 10 
61 20 35 10 
62 85 49 10 
63 64 1 8 
64 54 37 5 
65 85 17 3 
66 18 57 5 
67 62 19 5 
68 43 27 5 
69 52 22 10 
70 72 20 5 
71 53 47 4 
72 26 35 5 
73 75 20 10 
74 52 49 7 
75 68 3 0 
76 69 8 5 
77 80 34 10 
78 60 31 6 
XIII 
 
79 28 31 6 
80 48 54 6 
81 37 31 9 
82 25 4 0 
83 25 6 8 
84 69 34 9 
85 60 11 10 
86 78 29 10 
87 96 11 10 
88 56 33 6 
89 68 18 8 
90 54 82 10 
91 72 22 8 
92 91 25 8 
93 78 67 10 
94 51 69 9 
95 44 37 7 
96 99 15 10 
97 36 14 9 
98 67 34 10 
99 39 35 4 
100 56 37 8 
GREYS DQOL – Greys Dysphagia Quality of Life  
SF-36 – Short Form 36 




Appendix 2: Compliance of patients in completing questionnaires 
 
N 






1 100 100 100 
2 100 94.5 100 
3 100 100 100 
4 100 100 100 
5 76 72.2 100 
6 100 100 100 
7 100 97.2 100 
8 76 100 100 
9 84 100 0 
10 100 100 50 
11 100 100 0 
12 100 100 0 
13 84 97.2 100 
14 100 100 100 
15 100 100 100 
16 100 100 100 
17 100 100 100 
18 100 100 100 
19 100 100 100 
20 100 100 100 
21 100 91.7 0 
22 100 86.1 100 
23 100 100 100 
24 100 100 100 
25 100 97.2 100 
26 100 100 100 
27 100 97.2 0 
28 100 97.2 100 
29 100 97.2 100 
30 100 100 100 
31 96 97.2 100 
32 100 100 100 
33 100 86.1 100 
34 100 100 100 
35 100 97.2 0 
36 100 100 100 
37 100 100 100 
38 100 97.2 100 
39 100 100 100 
40 100 97.2 100 
41 100 100 100 
42 96 83.3 100 
43 96 100 100 
44 68 100 100 
45 100 88.9 100 
46 100 100 50 
47 100 97.2 0 
48 100 86.1 0 
49 100 97.2 50 
50 100 100 0 
51 100 97.2 100 
52 100 100 100 
XV 
 
53 100 100 100 
54 100 100 100 
55 100 100 0 
56 100 100 100 
57 100 100 100 
58 100 100 100 
59 100 100 100 
60 96 100 100 
61 96 100 100 
62 100 100 100 
63 92 77.8 100 
64 100 100 100 
65 96 100 100 
66 100 97.2 100 
67 100 94.4 50 
68 96 100 100 
69 100 83.3 100 
70 100 97.2 100 
71 100 100 100 
72 100 100 100 
73 80 97.2 100 
74 100 88.9 100 
75 100 100 100 
76 100 100 100 
77 100 97.2 100 
78 100 100 100 
79 100 97.2 100 
80 100 97.2 100 
81 84 100 100 
82 100 69.4 0 
83 100 100 100 
84 100 100 100 
85 100 100 100 
86 100 100 100 
87 96 100 100 
88 96 100 100 
89 100 100 100 
90 100 100 100 
91 100 100 100 
92 100 100 100 
93 100 77.8 100 
94 100 97.2 100 
95 100 97.2 100 
96 100 100 100 
97 100 91.7 100 
98 100 100 100 
99 100 94.4 100 
100 100 97.2 100 





Appendix 3: The Study Protocol 
 
The sections of the BREC Application relevant to the study protocol are included below: 
 
SECTION  3:  THE PROTOCOL 
  
Type of Study:  Clinical 
 
 
3.1  THE PROJECT:  
 
1. Aims (objectives of study) – please list. 
To develop a symptom-specific quality of life questionnaire for dysphagia relevant 
to our local population. 
 
2. Hypothesis to be tested. 
The new quality of life questionnaire scores correlate well with the scores of the 
existing tools. 
There is a significant change (improvement) in QOL scores from pre to post 
treatment in Dysphagia patients.  
 
 
3. Summary of the proposed research (restrict to 100 words) 
Specific objectives: 
1. To determine cut points in the new QOL scores that optimize sensitivity and 
specificity of predicting poor quality of life according to the gold standard.  
2. To attempt to determine whether Dysphagia scores which are currently 
available adequately assess quality of life of patients affected and are relevant 
to our local population. A locally relevant dysphagia QOL questionnaire may 
give us a better understanding of the impact dysphagia has on the QOL of our 
local population.  
 
Methods 
Cross –sectional validation study 
 
The proposed questionnaire will assess the frequency and severity of dysphagia, 
odynophagia, heartburn and chest pain, the frequency of regurgitation and extent of 
weight loss. Limitations to work and social activity and overall satisfaction with health 
will also be assessed. The visual analogue scale will be used to assess responses. 
Questions will be asked in the patients’ first language. Patients will be asked to 
complete the questionnaire on admission and after treatment has been administered. 
The Dysphagia score and short form – 36 (S-F 36) questionnaire will then be applied to 
the same patients and the results of the 3 questionnaires will be compared using 
Pearson’s correlation. Demographic and clinical data will also be collected. ROC 
analysis will be used to determine cut points in the new QOL score which optimally 
predict poor quality of life according to the previously validated gold standard 
questionnaires.  
 
Prospective cohort study 
XVII 
 
The minimum sample size for statistical significance was not possible to calculate since 
the expected difference of clinical relevance from pre to post treatment was not known. 
Thus the sample size to be used will be determined from logistical rather than statistical 
constraints. 1year of data collection will result in approximately 100 patients. This 
number will increased to account for dropout or death in the follow up period. The 
sample size can be increased if needed 
 
Patients will be assessed at baseline (pre treatment) and again post treatment (one 
week to one month) with the new QOL questionnaire. Statistical significance of the 
change will be assessed using paired t-tests (for quantitative data) or McNemar’s chi 
square tests (for categorical data)  
 
4.  Keywords (for database): 
Dysphagia, quality of life, oesophagus 
 
5.  Background and Literature:  
Dysphagia is a common symptom. Malignant obstruction is the commonest cause  with 
Benign strictures and motility disorders accounting for the remainder  The degree of 
dysphagia and its effect on quality of life (QOL) are poorly documented. QOL is 
adversely affected by dysphagia and this is under appreciated by physicians attending 
to these patients. A locally relevant and  composite dysphagia and quality of life 
questionnaire would give physicians a better understanding of the impact of dysphagia 
on our patients, and would allow an objective reproducible assessment of the success 
of different treatment modalities.  
 
Locally the most common cause is obstruction due to squamous carcinoma of the 
oesophagus with 600 new cases annually in the region. A variety of treatment options 
are available but comparative data on their effectiveness is lacking.    
Dysphagia has a direct negative impact on QOL. In addition, conditions which 
commonly present with dysphagia give rise to other symptoms which affect QOL. 
Common conditions presenting with dysphagia as well as symptoms associated with 




Causes of Dysphagia 
Malignancy  
Benign strictures (e.g. peptic stricture) 
Motility disorders (e.g. achalasia) 













A variety of medical, surgical and behavioral treatments to improve swallowing 
physiology are available. The effectiveness of these treatments is incompletely 
understood because comparative outcome assessments have been few.1 
 
For the majority of conditions mentioned above, management is palliative rather than 
curative. For this reason it is important to understand how these conditions and there 
treatments affect QOL of patients. While there are a large number of tools to assess 
dysphagia and its effects on quality of life. not all are disease or symptom specific. 
Examples include the dysphagia score and GI QOL score.   In addition the questions 
asked may not be relevant to our local population. The visual analogue scale (VAS) will 
be used in this study. This is a validated scale used to assess QOL which is easy to use 
and interpret. The visual analogue scale is an instrument that measures a characteristic 
or attitude that ranges across a continuum of values and cannot easily be directly 
measured.2  
 
Until now, a limited number of studies have been carried out on the social importance of 
dysphagia and its consequences on the quality of life.3 This fact underscores the need 
for a locally relevant quality of life assessment. 
 
 
6.  Key References:  (Give approximately 5 key references). 
1. McHorney C, et al. The SWAL-QOL outcomes tool for oropharyngeal dysphagia 
in adults. Dysphagia 2000; 15:115-121   
2. Gould D, et al. Journal of clinical nursing. 2001; 10: 697-706 
3. Farri A, et al. Social importance of dysphagia: its impact on diagnosis and therapy. Acta 
Otorhinolaryngol Ital. 2007; 27: 83-6 
4. Torquati, et al. Laparoscopic myotomy for achalasia. Predictors of successful outcome 
after 200 cases. Ann Surg. 2006;243:587-593 
5. Eypasch E, et al. Gastrointestinal quality of life index: developement, validationand 




3.2  PLAN OF INVESTIGATION: 
 
(a) Design and/or experimental procedures : 
In the case of Higher Degrees, please state name and department of person consulted 
regarding the design. 
a. A cross-sectional validation study 
b. A prospective pre and post treatment cohort study 




(b) Statistical Planning:  
 
Has this project been discussed with: 
 
 a professional statistician?    Yes   
 a person with a statistical background?  Yes:…………No:………… 
 
If yes,  (a) Name of statistician: Mrs T Esterhuizen 
 (b) Give details - outline statistical considerations such as randomisation, 




Patients will be asked to complete the questionnaire on admission and after treatment 
has been administered. The Dysphagia score and short form – 36 (S-F 36) 
questionnaire will then be applied to the same patients and the results of the 3 
questionnaires will be compared using Pearson’s correlation. Demographic and clinical 
data will also be collected. ROC analysis will be used to determine cut points in the new 
QOL score which optimally predict poor quality of life according to the previously 
validated gold standard questionnaires.  
The sample size will be a minimum of 100 patients.  This number will be increased to 
account for dropout or death in the follow up period.  
 
Patients will be assessed at baseline (pre treatment) and again post treatment (one 
week to one month) with the new QOL questionnaire. Statistical significance of the 
change will be assessed using paired t-tests (for quantitative data) or McNemar’s chi 
square tests (for categorical data)  
 




Clinical data:  Please indicate the numbers, source and age of the participants 





Age (humans):                      
Adults:……… 
 





Will you have control groups? 
 
Detail inclusion and exclusion criteria: 
All patients presenting with dysphagia as a primary symptom will be selected. 
All patients in whom dysphagia is not the primary symptom will be excluded 
All Patients lost to follow up will be excluded 
 
Describe recruitment process for all groups: 
 
(d) The Environment: 
1. Is this a multi-national study?      No.   If yes, state collaborating countries. 
 
2. List all sites in South Africa in which the project will be carried out. 
Greys Hospital 
Edendale Hospital 






3. Can the project have any negative consequences on participants, members of 
the public, researchers, field staff or the physical environment (incl. the 
laboratory)?    
 
  No:………  If yes, please give details. 
 
4. How many hours/week will the PI devote to this project? 
 Timetable the project in terms of the resources and time available. 
5 – 10 hours per week 
 
3.3  ETHICAL ASPECTS: 
 
(a) Responsibility:  In respect of any litigation which may result from this research: 
1. Are the pharmaceutical manufacturers prepared to take responsibility?   
 
  Not applicable:……… 
 If yes, please supply details. 
 
2. Have you ensured that reimbursement for participants and investigators is in 
accordance with 1) Guidelines for Good Practice in the Conduct of Clinical Trials 
in Human Participants in South Africa – Department of Health (2006) – and 2) 
Ethics in Health Research: Principles, Structures and Processes – (2004)? 
 
 Yes:………   If no, please explain. 
 
3. If this project is to be conducted at another institution, is additional ethical 
clearance approval required?  
 
 Not Applicable:…………..If no, please explain. 
 
 
(b)  Incentives / Reimbursement 
1. List any incentives, explicit and implicit, that have or will be offered to study 
participants, either to recruit or to retain within the study. 
None 
2. List reimbursement / compensation for participation in the study (e.g. travel 
costs, out of pocket expenses, etc.). 
N/A 
 
(c) Potential risks or discomfort: 
Compared to persons or patients with similar conditions indicate, for each study 
group, the potential additional 
 
 Risk - None 
 Discomfort - None 
 
(d) Health Service Utilisation: 
Compared with persons or participants with similar conditions indicate, for each study 




 Duration of hospital stay (days): 0  
 Outpatient attendances (number): 0  
 Laboratory services used: None 
 Samples to be drawn: none  
 Extent of nursing involvement: Assist with explaining questionnaire to patient 
 
Have the nursing team who will be involved in the study been informed of the study 
and the nursing involvement which will be required? 
   






In the case of participants drawn from patient populations, indicate, in respect of 
each sub-group, how management differs from that usually offered to patients with 
similar conditions. 
 
No difference in management 
(f) Community Consultation: N/A 
In the case of community based studies, explain what consultation is planned within 
the community at the following stages: 
 
1. Preparation 
2. Implementation of the study and  
3. Dissemination of the results thereafter 
 
 
(g) State the expected benefits arising from this study under the following 
headings: 
 
1.      Possible direct benefits to study participants 
 
2. Clinical care 
Ability to assess the effect of certain conditions on quality of life of patients 
Ability to assess the effect of treatment of dysphagia on quality of life 
Ability to assess adequacy of treatment of dysphagia 
 




4. Prospects of tested intervention being available to the study population if 
proven effective. 
 
5. Other (Specify) 
XXII 
 














           Frequency 0=never 1=<1d/week 2=1d/week 3=2-3d/week 4=4-6d/week 5=daily 
            Severity 0=none 1=very mild 2=mild 3=moderate 4=mod. severe 5=severe 
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Appendix 5: The SF-36 Questionnaire 
 
Instructions for completing the questionnaire: 
Please answer every question. Some questions may look like others, but each one is different. 
Please take the time to read and answer each question carefully by filling in the bubble that 
best represents your response. 
1. In general, would you say your health is? 
□ Excellent 





2. Compared to one year ago, how would you rate your health in general now? 
□ Much better now than a year ago 
□ Somewhat better now than a year ago 
□ About the same as one year ago 
□ Somewhat worse now than one year ago 
□ Much worse now than one year ago 
 
3. The following items are about activities you might do during a typical day. Does your health 
now limit you in these activities? If so, by how much? 
 
a. Vigorous activities, such as running, lifting heavy objects, participating in strenuous 
sports. 
□ Yes, limited a lot 
□ Yes, limited a little 




b. Moderate activities, such as moving a table, pushing a vacuum cleaner,    bowling or 
playing golf? 
□ Yes, limited a lot 
□ Yes, limited a little 
□ No, not limited at all 
       
c. Lifting or carrying groceries. 
□ Yes, limited a lot 
□ Yes, limited a little 
□ No, not limited at all 
 
d. Climbing several flights of stairs. 
□ Yes, limited a lot 
□ Yes, limited a little 
□ No, not limited at all 
 
e. Climbing one flight of stairs 
 
□ Yes, limited a lot 
□ Yes, limited a little 
□ No, not limited at all 
 
f. Bending, kneeling or stooping 
□ Yes, limited a lot 
□ Yes, limited a little 




g. Walking more than one mile 
□ Yes, limited a lot 
□ Yes, limited a little 
□ No, not limited at all 
 
h. Walking several blocks 
□ Yes, limited a lot 
□ Yes, limited a little 
□ No, not limited at all 
 
i. Walking one block 
□ Yes, limited a lot 
□ Yes, limited a little 
□ No, not limited at all 
 
j. Bathing or dressing yourself 
□ Yes, limited a lot 
□ Yes, limited a little 
□ No, not limited at all 
 
4. During the past 4 weeks, have you had any of the following problems with your work or other 
regular activities as a result of physical health? 
 
a. Cut down the amount of time you spent on work or other activities? 
□ Yes 
□ No 














5. During the past 4 weeks, have you had any of the following problems with your work or other 
regular activities as a result of any emotional problems? 
 












6. During the past 4 weeks, to what extent has your physical health or emotional problems 
interfered with your normal social activities with friends, family, neighbours or groups? 





□ Quite a bit 
□ Extremely 
 
7. How much bodily pain have you had during the past 4 weeks? 
□ Not at all 
□ Slightly 
□ Moderately 
□ Quite a bit 
□ Extremely 
 
8. During the past 4 weeks, how much did pain interfere with your normal work (including both 
work outside the home and housework)? 
□ Not at all 
□ Slightly 
□ Moderately 
□ Quite a bit 
□ Extremely 
 
9. These questions are about how you feel and how things have been with you during the past 4 
weeks. For each question, please give the one answer that comes closest to the way you have 
been feeling. How much of the time during the past 4 weeks. 
   
  a. Did you feel full of pep? 
□ All of the time  
□ Most of the time 
□ A good bit of the time 
□ Some of the time 
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□ A little of the time 
□ None of the time 
 
   b. Have you been a very nervous person? 
□ All of the time  
□ Most of the time 
□ A good bit of the time 
□ Some of the time 
□ A little of the time 
□ None of the time 
 
  c. Have you felt so down in the dumps nothing could cheer you up? 
□ All of the time  
□ Most of the time 
□ A good bit of the time 
□ Some of the time 
□ A little of the time 
□ None of the time 
 
d. Have you felt calm and peaceful 
□ All of the time  
□ Most of the time 
□ A good bit of the time 
□ Some of the time 
□ A little of the time 




e. Did you have a lot of energy? 
□ All of the time  
□ Most of the time 
□ A good bit of the time 
□ Some of the time 
□ A little of the time 
□ None of the time 
 
f. Have you felt downhearted and blue? 
□ All of the time  
□ Most of the time 
□ A good bit of the time 
□ Some of the time 
□ A little of the time 
□ None of the time 
 
g. Did you feel worn out? 
□ All of the time  
□ Most of the time 
□ A good bit of the time 
□ Some of the time 
□ A little of the time 
□ None of the time 
 
h. Have you been a happy person? 
□ All of the time  
□ Most of the time 
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□ A good bit of the time 
□ Some of the time 
□ A little of the time 
□ None of the time 
 
i. Did you feel tired? 
□ All of the time  
□ Most of the time 
□ A good bit of the time 
□ Some of the time 
□ A little of the time 
□ None of the time 
 
10. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interferes with your social activities (like visiting friends, relatives, etc.)? 
□ All of the time  
□ Most of the time 
□ A good bit of the time 
□ Some of the time 
□ A little of the time 
□ None of the time 
 
11. How TRUE or FALSE is each of the following statements for you? 
      
      a. I seem to get sick a little easier than other people 
□ Definitely true 
□ Mostly true 
□ Don’t know 
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□ Mostly false 
□ Definitely false 
 
       b. I am as healthy as anybody I know 
□ Definitely true 
□ Mostly true 
□ Don’t know 
□ Mostly false 
□ Definitely false 
 
c. I expect my health to get worse 
□ Definitely true 
□ Mostly true 
□ Don’t know 
□ Mostly false 
□ Definitely false 
 
d. My health is excellent 
□ Definitely true 
□ Mostly true 
□ Don’t know 
□ Mostly false 















Type of dwelling:_________________________________________ 
 



















                                                        
1) How often do you experience difficulty with swallowing liquids? 
 
0(Never)          4(occasionally)                    8(often)         10(always)          
 ___________________________________________________ 
                                                                          
 
2) How often do you experience difficulty with swallowing soft foods? 
 
0(Never)          4(occasionally)                     8(often)         10(always)          
 ___________________________________________________ 
                                                                                             
 
3) How often do you experience difficulty with swallowing raw hard fruits? 
 
   0(Never)          4(occasionally)                       8(often)         10(always)          
       ___________________________________________________ 
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4) How often do you experience difficulty with swallowing meat? 
 
0(Never)          4(occasionally)                   8(often)         10(always)         |                                                                                              
___________________________________________________ 
                                                                                                     
5) How bad is your difficulty in swallowing when swallowing liquids?   
 
 
0(none)                                                                           10(most severe) 
___________________________________________________ 
                                                                                      
 
 
6) How bad is your difficulty in swallowing when swallowing soft foods?   
 
 





7) How bad is your difficulty in swallowing when swallowing raw hard fruit?   
 
0(none)                                                                            10(most severe)  
___________________________________________________ 
                                                              
 
 
8) How bad is your difficulty in swallowing when swallowing meat?   
 







9) How often do you experience pain when swallowing liquids? 
 
0(Never)          4(occasionally)                    8(often)         10(always)          
  ___________________________________________________                                                                                      
 
10) How often do you experience pain when swallowing soft foods? 
 
0(Never)          4(occasionally)                     8(often)         10(always)          





11) How often do you experience pain when swallowing raw hard fruits? 
 
0(Never)          4(occasionally)                     8(often)         10(always)          
   ___________________________________________________ 
                                                                                           
 
12) How often do you experience pain when swallowing meat? 
 
0(Never)          4(occasionally)                     8(often)         10(always)          
   ___________________________________________________                                                                                       
 
                                                                                                            
13) How bad is your pain on swallowing when swallowing liquids?   
 
 




14) How bad is your pain on swallowing when swallowing soft foods?   
 
 
0(none)                                                                              10(most severe) 
   ___________________________________________________                                                                                
 
 
15) How bad is your pain on swallowing when swallowing raw hard fruit?   
 
0(none)                                                                             10(most severe) 
 ___________________________________________________ 
                                                                                             
 
16) How bad is your pain on swallowing when swallowing meat?   
 
0(none)                                                                             10(most severe) 
  ___________________________________________________ 
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Chest pain c 
 
17) How often do you get chest pain after eating? 
 
0(Never)          4(occasionally)                   8(often)         10(always)          
 ___________________________________________________ 
                                                                                            
 
18) How severe is your chest pain after eating? 
 
 
0(none)                                                                              10(most severe) 
   ___________________________________________________                                              
 
                                    
                                     
Heartburn d 
 
19) How often do you experience heartburn (a burning sensation in your chest 
extending from your stomach towards your throat)? 
 
0(Never)          4(occasionally)                   8(often)         10(always)       
    
  ___________________________________________________ 
                                                                                         
 
20) How severe is your heartburn? 
 
0(none)                                                                             10(most severe) 
  ___________________________________________________ 
                                                                                          
 
Frequency of regurgitation e 
 
 
21) How often do you experience regurgitation (food returning to your mouth after 
swallowing)? 
 
0(Never)          4(occasionally)                   8(often)         10(always)          
 ____________________________________________________  
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Amount of weight loss f 
 
22) How much weight have you lost since being ill? 
 
0(None)                                                                            10(>10kg) 
  ___________________________________________________ 
                                                                                           
 
Limitation of social activity g 
 
23) How much has your illness affected your social life? 
 
0(None)             4(mild)                 6(moderate)                10(no social life) 
   ___________________________________________________ 
                                                                                          
 
Limitation of work h 
 
24) How much has your illness limited your work? 
 
0(None)             4(mild)                 6(moderate)               10(unable to work)  
 ___________________________________________________ 
 
Satisfaction with current state of health i 
 
25) How satisfied are you with your current state of health? 
 
0(completely satisfied)                                                    10(completely dissatisfied) 
 ___________________________________________________ 
                                                                                            
a   - Dysphagia can be defined as difficulty in swallowing or the sensation of food getting 
stuck while swallowing 
b – Odynophagia can be defined as the experience of painful swallowing or feeling pain 
while swallowing 
c – Chest pain should be felt behind the sternum, not while swallowing and not be due 
to other causes, like cardiac ischaemia 
d – Heartburn if defined as a burning sensation in the chest usually progressing from 
the epigastric area upwards to the chest and throat 
e – Regurgitation can be defined as the return of partially digested or undigested food to 
the mouth after swallowing 
f – If the exact amount of weight loss is unknown an estimation can be given. The 
patient may report it as a change in size of clothes 
g – Social activity will vary among different socioeconomic groups and examples may 
be given (like eating at a restaurant or eating with family or friends)  
h – Limitation of work may include employement and/or housework 
i – This should be an indication of overall feeling of well-being or illness 
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Appendix 7: Translated Dysphagia Score 




Kangakhi 0=akukaze 1=< usuku/     
       esontweni 
2=usuku/                     
    esontweni 
3=2-3 
izinsuku/  
          
esontweni 
4=4-6 izinsuku/    





0=akukho 1=kancane  
    kakhulu 
2= kancane 3=okuphakath
i  




Appendix 8: Translated S-F 36 questionnaire 
 
0SF-36 Uphenyo Ngezempilo 
Imithetho yokugcwalisa uhlu lwemibuzo: Sicela uphendule yonke imibuzo. Kunemibuzo 
ebonakala ifana neminye, kodwa uma ubhekisisa ayifani. Uyacelwa ukuthi ube nesineke 
ufundisise bese uphendula yilowo nalowo mbuzo ngokucophelela, ngokugcwalisa ukhethe 





Umuntu osiza lowo ogcwalisa leli 
fomu:_________________________________________________ 
 
1. Ngokujwayekile ungathini ngempilo yakho? 
  Inhle ngokubabazekayo 
  Yinhle kakhulu 
  Yinhle 
  Iyemukeleka 
  Yimbi 
2. Uma uqhathanisa nesikhathi esingangonyaka esedlulile ungathi impilo yakho injani      
    manje? 
  Ingcono kakhulu kunesikhathi esingangonyaka esedlule 
  Ingconywana kunesikhathi esingangonyaka esedlule  
  Cishe kufane nje 
  Ngingathi kuya ngokuba kubi kunesikhathi esingangonyaka esedlule 
  Kubi kakhulu manje kunesikhathi esingangonyaka esedlule 
3. Loku okulandelayo kukhuluma ngezinto ondgase uzenze ngosuku ulujwayelekile. 
    Ngakube impilo yakho manje iyakuvimbela yini ukuthi wenze izinto ojwayele       
    ukuzenza? Uma kunjalo, kangakanani? 
a. Imisebenzi edinga amandla amakhilu njengokugijima, ukuqukula izinto ezisindayo    
    nokudlala imidlalo edinga amandla. 
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     Yebo, kuyangivimbela kakhulu 
  Yebo, kuyangivimbela nje kancane 
  Cha, akungivimbeli nakancane 
b. Imisebenzi edinga amandl aphakathi nendawo, njengokududula itafula, ukusebenzisa  
   ushini wokushanela ikhaphethi i-vaccum cleaner nokudlala igalofu? 
  Yebo, kuyangivimbela kakhulu 
  Yebo, kuyangivimbela nje kancane 
  Cha, akungivimbeli nakancane 
c. Ukuphakamisa nokuthwala izimpahla zokudla okade uzithenga 
  Yebo, kuyangivimbela kakhulu 
  Yebo, kuyangivimbela nje kancane 
  Cha, akungivimbeli nakancane 
d. Ukwenyuka izitebhisi eziyingcosana. 
  Yebo, kuyangivimbela kakhulu 
  Yebo, kuyangivimbela nje kancane 
  Cha, akungivimbeli nakancane 
 e. ukwenyuka izitebhisi ezimbalwa. 
  Yebo, kuyangivimbela kakhulu 
  Yebo, kuyangivimbela nje kancane 
  Cha, akungivimbeli nakancane 
 f. Ukugoba nokuguqa. 
  Yebo, kuyangivimbela kakhulu 
  Yebo, kuyangivimbela nje kancane 
  Cha, akungivimbeli nakancane 
 g. ukuhamba ngaphezu kwamakhilomitha amabili. 
  Yebo, kuyangivimbela kakhulu 
  Yebo, kuyangivimbela nje kancane 
  Cha, akungivimbeli nakancane 
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h Ukuhamba ibanga elingadlula izindlu eziyidlanzana edolobheni. 
  Yebo, kuyangivimbela kakhulu 
  Yebo, kuyangivimbela nje kancane 
  Cha, akungivimbeli nakancane 
 i Ukuhamba ibanga elingadlula isakhiwo esisodwa edolobheni. 
  Yebo, kuyangivimbela kakhulu 
  Yebo, kuyangivimbela nje kancane 
  Cha, akungivimbeli nakancane 
 j Ukuzigeza nokuzigqokisa. 
  Yebo, kuyangivimbela kakhulu 
  Yebo, kuyangivimbela nje kancane 
  Cha, akungivimbeli nakancane 
4. Emasontweni amane adlule uke waba nenye yalezi nkinga ezilandelayo emsebenzini    
    nakwezinye izinto ozenzayo okube umphumelo wesimo sempilo yakho? 
 a. Wehlise isikhathi osichitha emsebenzini wakho nakokunye okwenzayo 
   Yebo 
   Cha 
 b. Wenze umsebenzi ongaphansi kwalokho ofisa ukukwenza 
   Yebo 
   Cha 
 c. Ube nokuphazamiseka emsebenzini nokunye ojwayele ukukwenza 
   Yebo 
   Cha 
d. Ube nobunzima ekwenzeni umsaebenzi nokunye ojwayele ukukwenza(uthathe     
     isikhathi eside kunesijwayelekile)? 
   Yebo 




5. Emasontweni amane adlule uke waba nenye yalezi nkinga ezilandelayo emsebenzini    
    nakwezinye izinto ozenzayo okube umphumelo wesimo sempilo yakho? 
 a. Wehlise isikhathi ovame ukusichitha emsebenzini wakho nokunye? 
   Yebo 
   Cha 
b. Wenze ngaphansi kwalokho obufisa ukukwenza? 
   Yebo 
   Cha 
 c. Awuzange ukwazi ukwenza umsebenzi wakho nokunye ngendlela    
     enokucophelela njengoba ujwayele ukwenza? 
   Yebo 
   Cha 
6. Kulamasonto amane adlule ngabe impilo yakho yomzimba nomphefumulo    
    ikuphazamise kangaknani ukuhlalisana kahle kwakho nabangani bakho, omakhelwane,  
    umndeni wakho kanye nabanye osebenzisana nabo? 
  Ayibathintanga nakancane 
  Ibathintile kancane 
  Ibathinte kakhudlwana 
  Ibathinte impela 
  Ibathinte kakhulu 
7. Kungabe zingakanani izinhlungu emzimbeni wakho kulamasonto amane edlule? 
  Ayibathintanga nakancane 
  Ibathintile kancane 
  Ibathinte kakhudlwana 
  Ibathinte impela 
  Ibathinte kakhulu 
8. Kulamasonto amane adlule ngabe izinhlungu ziyiphazamise ngakanani indlela ohlala  
    usebenza ngayo(umsebenzi wangaphandle kwasekhaya nowasendlini)? 
  Ayibathintanga nakancane 
  Ibathintile kancane 
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  Ibathinte kakhudlwana 
  Ibathinte impela 
  Ibathinte kakhulu 
9. Lemibuzo iqndene nokuthi uzizwa unjani nokuthi izinto bezikuhambela kanjani       
    kulamasonto amane adlule. Embuzweni ngamunye soicela usinike impendulo eyodwa        
    ocabanga ukuthi iyona echaza ismo sakho. Singakanani isikhathi kulamasonto adlule: 
 a. Lapho wazizwa uphila kahle kakhulu? 
   Sonke isikhathi 
   Isikhathi esiningi 
   Isikhashana nje impela 
   Ngesinye isikhathi 
   Izikhashana eziyingcosana/ezimbalwa 
   Akukaze kwenzeke nakancane 
 
 b. Ngabe usuke waba umuntu ohlala  unovalo? 
   Sonke isikhathi 
   Isikhathi esiningi 
   Isikhashana nje impela 
   Ngesinye isikhathi 
   Izikhashana eziyingcosana/ezimbalwa 
   Akukaze kwenzeke nakancane 
 
 c. Uke wazizwa unenhliziyo ebuhlungu nephansi wezwa sengathi akukholutho  
                olungakujabulisa? 
    Sonke isikhathi 
   Isikhathi esiningi 
   Isikhashana nje impela 
   Ngesinye isikhathi 
   Izikhashana eziyingcosana/ezimbalwa 
   Akukaze kwenzeke nakancane 
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 d. Uzizwe unokuthula noxolo ngaphakathi kuwena 
   Sonke isikhathi 
   Isikhathi esiningi 
   Isikhashana nje impela 
   Ngesinye isikhathi 
   Izikhashana eziyingcosana/ezimbalwa 
   Akukaze kwenzeke nakancane 
 e. Uke wazizwa unomfuthop namandla amaningi? 
   Sonke isikhathi 
   Isikhathi esiningi 
   Isikhashana nje impela 
   Ngesinye isikhathi 
   Izikhashana eziyingcosana/ezimbalwa 
   Akukaze kwenzeke nakancane 
 f. Uke wazizwa wehlile emoyeni kukubi konke? 
   Sonke isikhathi 
   Isikhathi esiningi 
   Isikhashana nje impela 
   Ngesinye isikhathi 
   Izikhashana eziyingcosana/ezimbalwa 
   Akukaze kwenzeke nakancane 
g. Uke wazizwa ukhathele kakhulu? 
   Sonke isikhathi 
   Isikhathi esiningi 
   Isikhashana nje impela 
   Ngesinye isikhathi 
   Izikhashana eziyingcosana/ezimbalwa 
XLIV 
 
   Akukaze kwenzeke nakancane 
h. Umthetho wakho ungumuntu ohlala eneme? 
   Sonke isikhathi 
   Isikhathi esiningi 
   Isikhashana nje impela 
   Ngesinye isikhathi 
   Izikhashana eziyingcosana/ezimbalwa 
   Akukaze kwenzeke nakancane 
i. Uke wazizwa ukhathele? 
   Sonke isikhathi 
   Isikhathi esiningi 
   Isikhashana nje impela 
   Ngesinye isikhathi 
   Izikhashana eziyingcosana/ezimbalwa 
   Akukaze kwenzeke nakancane 
10. Emasontweni amane adlule singakanani isikhathi lapho impilo yakho yomzimba  
      kanye nezinkingan zomphefumulo kuphazamise izinto ojwayele ukuzenza    
      (njengokuvakashela abangane, izihlobo nokunye)?                                             
   Sonke isikhathi 
  Isikhathi esiningi 
  Isikhashana nje impela 
  Ngesinye isikhathi 
  Izikhashana eziyingcosana/ezimbalwa 






11. KiyiQINISO kangakanani kumbe kungaMANGA kangakanani lokhu okulandelayo     
      kuwena? 
a. Ngivama ukugula kalula kunabanye abantu 
  Kuyiqiniso kakhulu 
  Kuvmise ukuba yiqiniso 
  Angazi 
  Kuvamiso ukungabi yiqiso 
  Akusilona iqiniso nakancane  
b. Ngiphila njengabo bonke engibaziyo 
  Kuyiqiniso kakhulu 
  Kuvmise ukuba yiqiniso 
  Angazi 
  Kuvamiso ukungabi yiqiso 
  Akusilona iqiniso nakancane 
c. Ngilindele ukuthi impilo yami iye ngokuba yimbi kunalokhu 
  Kuyiqiniso kakhulu 
  Kuvmise ukuba yiqiniso 
  Angazi 
  Kuvamiso ukungabi yiqiso 
  Akusilona iqiniso nakancane 
 d. Impilo yami yinhle kakhulu 
  Kuyiqiniso kakhulu 
  Kuvmise ukuba yiqiniso 
  Angazi 
  Kuvamiso ukungabi yiqiso 




Appendix 9: Translated GREYS DQOL questionnaire 
 
IMIBUZO YOCWANINGO ENGABUZWA  
Imininingwane eqondene nalowo ophendula lemibuzo 
Igama:_______________________Iminyaka yobudala:____Ubulili:____Ubuzwe:_____ 
Ikheli:__________________________________________________________________ 
Uhlobo lwendlu yakhe:____________________________________________________ 
Izinga lemfundo afinyelela kulo:_____________________________________________ 
Umsebenzi awenzayo: ____________________________________________________ 
 
Imininingwane emaqondana nokugula 
Igama lesifo esimphethe:_______________________________________ 
Indlela aselashwe ngayo:_______________________________________ 
Usuku  alashwa ngalo:_________________________________________ 




Ukugwinya kalukhuni a 
1) Kuvame kangakanani ukuthi ube nobulukhuni bokugwinya izinto eziphuzwayo? 
0(akwenzeki)         4(akuvamisile)             (kuvamisile)              10(njalo nje) 
___________________________________________________ 
 
2) Kuvame kangakanani ukuthi ube nobulukhuni bokugwinya ukudla okuqinile? 




3) Kuvamise kangakanani ukuthi ube nobulukhuni bokugwinya izithelo ezingaphekwanga 
0(akwenzeki)        4(akuvamile)            8(kuvamile)                    10(njalo nje) 
___________________________________________________ 
4) Kuvamise kangakanani ukuthi ube nobulukhuni uma ugwinya inyama? 
0(akwenzeki)          4(akuvamile)                8(kuvamile)              10(njalo nje) 
___________________________________________________ 
5) Kulukhuni kangakanani ukugwinya iziphuzo namanzi?  
0(akulukhuni)                                                                                   10(kulukhuni kakhulu) 
___________________________________________________ 
6) Kulukhuni kangakanani ukugwinya ukudla okuthambile? 
0(akulukhuni)                                                                                    10(kulukhuni kakhulu) 
___________________________________________________ 
7) Kulukhuni kangakanani ukugwinya izithelo ezingaphekwanga? 
0(akulukhuni)                                                                                    10(kulukhuni kakhulu) 
___________________________________________________ 
8) Kulukhuni kangakanani ukugwinya inyama? 
0(akulukhuni)                                                                                    10(Kulukhuni kakhulu) 
___________________________________________________ 
 
Ukuba nobuhlungu uma ugwinya b  
9) Kuvamise kangakanani ukuthi ube nobuhlungu uma ugwinya okuphuzwayo njengamanzi? 
0(akwenzeki)        4(kuqabuka nje)        8(kuvamisile)               10(njalo nje) 
___________________________________________________ 
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10) Kuvamise kangakanani ukuthi  uzwe ubuhlungu  uma ugwinya ukudla okuthambile? 
0(akwenzeki)           4(kuqabuka nje )       8(kuvamile)               10(njalo nje) 
___________________________________________________ 
11) Kuvamise kangakanani ukuthi ube nobuhlungu uma ugwinya iaithelo ezingaphekwanga?  
0(akwenzeki)         4(kuqabuka nje)         8(kuvamile)                10(njalo nje) 
___________________________________________________ 
12) Kuvamise kangakanani ukuthi uzwe ubuhlungu uma ugwinya inyama? 
0(akwenzeki)      4(kuqabuka nje)            8(kuvamile)                10(njalo nje) 
___________________________________________________ 
13)  Kubuhlungu kangakanani ukugwinya uma ugwinya amanzi nezinye iziphuzo? 
0(akubuhlungu)                                                                                    10(kubuhlungu kakhulu) 
___________________________________________________ 
14) Kubuhlungu kangakanani uma ugwinya ukudla okuthambile? 
0(akubuhlungu)                                                                                10(kubuhlungu kakhulu) 
___________________________________________________ 
15) Kubuhlungu kangakanani uma ugwinya izithelo ezingaphekwanga? 
0(akubuhlungu)                                                                                10(kubuhlungu kakhulu) 
___________________________________________________ 
16) Kubuhlungu kangakanani uma ugwinya inyama? 





Ubuhlungu besifuba c 
17) Kuvamise kangakanani ukuthi uzwe izinhlungu esifubeni emva kokudla? 
0(akwenzeki)       4(kuqabuka nje)                  8(kuvamile)        10(njalo nje) 
___________________________________________________ 
18) Kubuhlungu kangakanani esifubeni emva kokudla? 
0(akubuhlungu)                                                                                10(kubuhlungu kakhulu) 
___________________________________________________ 
Isilungulela d 
19) Kuvamise kangakanani ukuthi ube nesilungulela (ukushisa okusesifubeni kusuka esiswini 
kudlulele emphinjeni) 
0(angibi nasilungulela) 4(kuqabuka nje)    8(kuvamile)            10(njalo nje) 
___________________________________________________ 
20) Sikuphatha kangakanani isilungulela? 
0(asingiphathi)                                                                                 10(singiphatha kakhulu) 
___________________________________________________ 
Ukuvama ukubuyisa e 
21) Uvamise kangakanani ukubuyisa(ukubuya kokudla osukugwinyile) 
0(akwenzeki)    4(kuke kwenzeke)  8(Kuvanile ukwenzeka)     10(njalo nje) 
___________________________________________________ 
Izinga lokwehla kwesisindo somzimba f 
22) Sehle kangakanani isisindo somzimba wakho kusukela ngesikhathi uqala ukugula? 







Ukungasakwazi ukubamba iqhaza emphakathini njengakuqala g 
23) Ngabe ukugula kwakho kuyiphazamise kangakanani indlela ojwayele ukuphila ngayo 
emphakathini? 
0(akuzange)            4(kancane)            6(kakhudlwana)              10(akusavumi ngenze lutho) 
___________________________________________________ 
Ukungasakwazi ukusebenza h 
24) Ukugula kwakho kukuphazamise kangakanani emsebenzini? 
0(akuzange)          4(kancane)              6(kakhudlwana)             10(akusebenzeki) 
___________________________________________________ 
Ukweneliseka ngempilo yakho njengamanje i 
25) Weneliseke kangakanani ngesimo sempilo yakho njengamanje.  
0(ngeneliseke kakhulu)                                                                   10(angenelisekanga nakancane)   
___________________________________________________ 
a –Dysphagia-leligama lisho ukuba lukhuni kokugwinya, okwenza umuntu ezwe sengathi ukudla 
kubambeke emphinjeni.                         
b- Odynophagia- leligama lisho ukuzwa ubuhlungu ngesikhathi ugwinya  
c-ubuhlungu besifuba kufanele ubuzwe emva kwethambo elihlanganisa izimbambo ngaphambili 
esifubeni. Lobuhlungu akubona obenzeka uma ugwinya kumbe okwenziwa isifo esenziwaa  
ukuncipha kwegazi enhliziyweni 
d-Heartburn-Isilungulela usizwa ngokushisa okuzwa esifubeni; kusuka esiswini kunyuke kuze 
esifubeni nasemphinjeni. 
e-Ukubuyisa kusho ukubuya kokudla osekusesiswini sekugayekile noma kungakagayeki kahle 
kubuyele emlonyeni kade sewukugwinyile.  
f-Uma umuntu engazi ukuthi uselahlekelwe yisisindo esingakanani kunganikezwa isilinganiso 
njengokuthi nje bengigqoka ingubo engaka sengigqoka engaka.  
g-Ukubamba iqhaza emphakathini kuyehlukana, kuye ngokuthi lowo muntu uphila impilo 
enjani;  imifanekiso inganikezwa  (enjengokudla ezindaweni ezidayisa ukudla noma ukudla  
nomndeni kumbe nabangani)  
h-Ukungasakwazi ukusebenza ngendlela ejwayelekile kungasho ukuqashwa emsebenzini kanye 
/noma umsebenzi wasendlini.  




Appendix 10 : Results of unvariate regression analysis 
 
GREYS DQOL vs. Gender 
GREYS 
DQOL 
Coeff Std err t p>[t] 95% CI 
Gender 8.31 4.74 1.75 0.08 -1.08-17.72 
Cons 49.51 6.93 7.14    0.00 35.75-63.28 
GREYS DQOL vs. Age 
GREYS 
DQOL 
Coeff Std err t p>[t] 95% CI 
Age 0.22 0.15 1.43 0.15 -0.08-0.54 
Cons 47.77 9.68 4.94 0.00 28.55-66.99 
GREYS DQOL vs. Level of education 
GREYS DQOL Coeff Std err t p>[t] 95% CI 
Level of 
education 
-2.88 4.009 -0.72 0.47 -10.85-5.08 
Cons 67.009 7.85 8.53 0.00 51.38-82.62 
SF-36 vs. Level of education 
SF-36 reciprocal Coeff Std err t p>[t] 95% CI 
Level of 
education 
-10.48 3.18 -3.29 0.001 -16.82- -4.14 
Cons 88.51 6.24 14.17 0.00 76.09-100.93 
DS vs. Level of education 
DS Coeff Std err t p>[t] 95% CI 
Level of 
education 
-0.49 0.59 -0.82 0.41 -1.68-0.69 
Cons 8.007 1.17 6.82 0.00 5.67-10.33 
DS vs. Age 
DS Coeff Std err t p>[t] 95% CI 
Age 0.007 0.02 0.33 0.74 -0.03-0.05 
Cons 6.60 1.42 4.64 0.00 3.78-9.43 
DS vs. Gender 
DS Coeff Std err t p>[t] 95% CI 
Gender -0.41 0.71 -0.58 0.56 -1.82-0.99 
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